<?xml version="1.0" encoding="US-ASCII" ?>
			<!-- RSS Generated By aesnet.org on 05/16/2012 at 06:32:01 PM -->
			<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
				<channel>
					<title>AES Resources in Epilepsy Research Opportunities</title>
					<link>http://www.aesnet.org/erc/funding/list.cfm</link>
					
					<atom:link href="http://www.aesnet.org/erc/funding/rss.cfm" rel="self" type="application/rss+xml" />
					
					<description>AES Resources in Epilepsy Research Funding Opportunities</description>
					<language>en-us</language>
					<copyright>&#169; 2012 American Epilepsy Society.  All Rights Reserved.</copyright>
					<lastBuildDate>Wed, 16 May 2012 06:32:01 EST</lastBuildDate>
			
					<item>
						<title>2012 CURE Challenge Award</title>
						
						<description><![CDATA[Sponsor: CURE Source: CURE Application Deadline:  Eligibility: This award will be presented to an established investigator* exploring cutting-edge approaches to curing epilepsy. Preference will be given to research addressing the more severe and refractory syndromes of epilepsy. International applicants are welcome. Researchers who serve on CURE&amp;amp;#8217;s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.*Established investigators are university faculty at the associate professor level or above. Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Application Information: CURE promotes research that advances the search for a cure, and addresses the goal of &amp;amp;#8220;no seizures, no side effects.&amp;amp;#8221; Successful applicants for the Challenge Award should propose research in at least one of the following priority areas: (1) the basic mechanisms of epileptogenesis; (2) the multifaceted causes of epilepsy; (3) the pediatric epilepsy syndromes; (4) new animal models of epilepsy. We specifically encourage studies that may not be currently fundable by other agencies, such as the NIH, because of their preliminary or unconventional nature. Other: 2012 FUNDING CYCLEDeadline for Receipt of LOI: December 13, 2011Notification of Invitation to Apply: early-February 2012Deadline for Receipt of Full Application: April 3, 2012Award Announcement: July 2012Earliest Project Start Date: August 1, 2012Letter of Intent: All applicants must submit a Letter of Intent. All LOIs are reviewed by CURE&amp;amp;#8217;s Scientific Advisory Board and Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.For questions, please contact Danielle Davis at the CURE office, 312.255-1801, or email danielle.davis@CUREepilepsy.org.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=67</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>2012 CURE Challenge Award</category>
						<guid isPermaLink="false">6DC8FAC0-78E3-B519-1E495FE042A2B21B</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>2012 CURE Innovator Award</title>
						
						<description><![CDATA[Sponsor: CURE Source: CURE Application Deadline: June 16, 2006 Eligibility: This award is available to both established and early career investigators*. International applicants are welcome. Researchers who serve on CURE&amp;amp;#8217;s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.* Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above. In exceptional cases, scientists at the postdoctoral level may be eligible for this award. Application Information: The CURE Innovator Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to epilepsy. The Innovator Award is not intended to support a logical progression of an already established research project but, instead, allows Principal Investigators (PIs) the opportunity to pursue innovative research studies. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation. Proposals must describe how the new idea will enhance existing knowledge of epilepsy or create an entirely new avenue for investigation. Research completed through an Innovator Award strives to provide sufficient preliminary data to enable the PI to prepare a proposal for future research.Preliminary data is not necessary to receive this grant.Areas of Interest: CURE seeks novel research projects that will address the goals of &amp;amp;#8220;no seizures/no side effects.&amp;amp;#8221;This program awards seed grants to researchers submitting innovative proposals that will provide new directions for epilepsy therapy, prevention and, ultimately, a cure. We specifically encourage studies that may not be currently fundable by other agencies, such as the NIH, because of their preliminary or unconventional nature. Other: 2012 FUNDING CYCLEDeadline for Receipt of LOI: September 20, 2011Deadline for Receipt of Full Application: November 8, 2011Award Announcement: December 2011Earliest Project Start Date: January 1, 2012Letter of Intent: All applicants must submit a Letter of Intent. All LOIs are reviewed by CURE&amp;amp;#8217;s Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.For questions, please contact Danielle Davis at the CURE office, 312.255-1801, or email danielle.davis@CUREepilepsy.org.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=23</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>2012 CURE Innovator Award</category>
						<guid isPermaLink="false">6DC8FACC-78E3-B519-1E49C66665FBB719</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>2012 CURE Multidisciplinary Award</title>
						
						<description><![CDATA[Sponsor: CURE Source: CURE Application Deadline: June 16, 2006 Eligibility: Eligibility: This program awards a joint seed grant in support of collaborative, multidisciplinary research undertaken by at least two investigators (including early career investigators*)&amp;amp;#8211; one investigator specifically specializing in epilepsy and one investigator outside the epilepsy field who is looking to extend his or her work into epilepsy research. Together, the investigators&amp;amp;#8217; joint efforts should be aimed at advancing CURE&amp;amp;#8217;s goal of &amp;amp;#8220;no seizures/no side effects.&amp;amp;#8221; Preference will be given to research addressing the more severe and refractory syndromes of epilepsy. International applicants are welcome. Researchers who serve on CURE&amp;amp;#8217;s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.* Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above. Application Information: CURE promotes collaborative, multidisciplinary research that advances the search for a cure, and addresses the goal of &amp;amp;#8220;no seizures, no side effects.&amp;amp;#8221; Successful applicants for the Multidisciplinary Award should propose research in at least one of the following priority areas: (1) the basic mechanisms of epileptogenesis; (2) the multifaceted causes of epilepsy; (3) the pediatric epilepsy syndromes; (4) new animal models of epilepsy. We specifically encourage studies that may not be currently fundable by other agencies, such as the NIH, because of their preliminary or unconventional nature. Applicants will be expected to pursue novel, multidisciplinary projects requiring the collaborative efforts of both investigators. The LOI (and subsequent application) should provide specific aims for the proposed work and background for the collaborative research effort. We encourage both new and continuing collaborative relationships between investigators. Invited applicants will be required to describe how each investigator will contribute to the proposed work through details of research design and methods, including where and how the specific projects will be accomplished. Additionally, the application will demonstrate an equitable distribution of budget costs. Successful applications are anticipated to pursue work that could not ordinarily be pursued by either of the investigators without collaborative effort. Other: 2012 FUNDING CYCLEDeadline for Receipt of LOI: December 13, 2011Notification of Invitation to Apply: early-February 2011Deadline for Receipt of Full Application: April 3, 2012Award Announcement: July 2012Earliest Project Start Date: September 1, 2012Letter of Intent: All applicants must submit a Letter of Intent. All LOIs are reviewed by CURE&amp;amp;#8217;s Scientific Advisory Board and Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.For questions, please contact Danielle Davis at the CURE office, 312.255-1801, or email danielle.davis@CUREepilepsy.org.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=29</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>2012 CURE Multidisciplinary Award</category>
						<guid isPermaLink="false">6DC8FADA-78E3-B519-1E49F95406B8A9F9</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>2012 CURE Sudden Unexplained Death in Epilepsy (SUDEP) Award</title>
						
						<description><![CDATA[Sponsor: CURE Source: CURE Application Deadline:  Eligibility: This award is available to both established and early career investigators*. International applicants are welcome. Researchers who serve on CURE&amp;amp;#8217;s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.* Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above. In exceptional cases, scientists at the postdoctoral level may be eligible for this award. Application Information: Every year, approximately 50,000 deaths occur in the United States from seizure-related causes including Sudden Unexplained Death in Epilepsy (SUDEP). However, there remains a huge lack of public awareness of SUDEP, and an urgent need for more research to determine underlying mechanisms and identify the causes of SUDEP. Recognizing these inadequacies and the devastating impact SUDEP has on families who have lost a loved one, CURE has established a targeted research program to advance the study of SUDEP.CURE seeks novel research projects that will address the goal of the prevention of SUDEP. This program awards seed grants to researchers submitting innovative proposals that will provide new directions for SUDEP research. We specifically encourage studies that may not be currently fundable by other agencies, such as the NIH, because of their preliminary or unconventional nature. CURE encourages collaborative projects; however, non-collaborative projects will be given equal consideration. Invited applicants who propose a collaborative project should describe how each investigator will contribute to the proposed work through details of research design and methods, including where and how the specific project will be accomplished. Labor and budget do not have to be equally distributed between investigators who choose to work collaboratively. Other: 2012 FUNDING CYCLEDeadline for Receipt of LOI: December 13, 2011Notification of Invitation to Apply: early-February 2012Deadline for Receipt of Full Application: April 3, 2012Award Announcement: July 2012Earliest Project Start Date: August 1, 2012Letter of Intent: All applicants must submit a Letter of Intent. All LOIs are reviewed by CURE&amp;amp;#8217;s Scientific Advisory Board and Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.For questions, please contact Danielle Davis at the CURE office, 312.255-1801, or email danielle.davis@CUREepilepsy.org.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=84</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>2012 CURE Sudden Unexplained Death in Epilepsy (SUDEP) Award</category>
						<guid isPermaLink="false">6DC8FAE6-78E3-B519-1E495BD504529EED</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>2012 CURE TAKING FLIGHT Award</title>
						
						<description><![CDATA[Sponsor: CURE Source: CURE Application Deadline: null Eligibility: These awards will be provided for senior postdoctoral fellows who have a minimum of 3 years postdoctoral experience, or clinical fellows who are Neurology Residents in their Neurology training who are considering doing Epilepsy Fellowships. Individuals from any country are eligible to apply; you do not have to be a USA citizen or working in the USA to apply for this award. All materials must be submitted in English. Application Information: CURE seeks to promote the careers of young investigators to allow them to develop a research focus independent of their mentor(s). Proposed research should address the ultimate goal of &amp;amp;#8220;no seizures/no side effects.&amp;amp;#8221; Researchers may propose basic or clinical studies involving human subjects, but this award mechanism is not intended to support clinical trials. Research that involves collaboration and a multidisciplinary approach is desirable. Applicant will be required to discuss how this avenue of research is independent from his or her mentor&amp;amp;#8217;s research, and will lead him or her to a path of independent epilepsy research. We encourage studies that will allow applicants to collect the data necessary to structure a successful NIH grant application. Letters of Support: All individuals invited to submit full applications will be required to submit two letters of support; one letter of support from their direct supervisor/mentor and one letter of support from another senior investigator/clinician familiar with the individual&amp;amp;#8217;s expertise and experience. Other: 2012 FUNDING CYCLEDeadline for Receipt of LOI: September 20, 2011Deadline for Receipt of Full Application: November 8, 2011Award Announcement: December 2011Earliest Project Start Date: January 1, 2012Letter of Intent: All applicants must submit a Letter of Intent. All LOIs are evaluated by scientific reviewers and the Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.For questions, please contact Danielle Davis at the CURE office, 312.255-1801, or email danielle.davis@CUREepilepsy.org.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=112</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>2012 CURE TAKING FLIGHT Award</category>
						<guid isPermaLink="false">6DC8FAF0-78E3-B519-1E49118307A2234E</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>2012 Prevention of Acquired Epilepsy Award</title>
						
						<description><![CDATA[Sponsor: CURE Source: CURE Application Deadline: March 17, 2006 Eligibility: Eligibility: This award will be presented to either an established or an early career investigator*. International applicants are welcome. Researchers who serve on CURE&amp;amp;#8217;s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.* Established investigators are university faculty at the associate professor level or above. Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Application Information: CURE seeks novel research projects of relevance to the prevention and treatment of acquired (post-injury) epilepsy including the cellular, molecular, and systems-level understanding of the underlying pathogenic mechanisms; specific approaches to interdict the development of acquired epilepsy; animal models of acquired epilepsy; and investigations of the impact, natural history, and epidemiology of acquired epilepsy. For the purposes of this program, &amp;amp;#8220;acquired epilepsy&amp;amp;#8221; is defined as epilepsy which results from injury to the brain, including traumatic brain injury, stroke, and brain tumor. Other: 2012 FUNDING CYCLEDeadline for Receipt of LOI: December 13, 2011Notification of Invitation to Apply: early-February 2012Deadline for Receipt of Full Application: April 3, 2012Award Announcement: July 2012Earliest Project Start Date: August 1, 2012Letter of Intent: All applicants must submit a Letter of Intent. All LOIs are reviewed by CURE&amp;amp;#8217;s Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.For questions, please contact Danielle Davis at the CURE office, 312.255-1801, or email danielle.davis@CUREepilepsy.org.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=22</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>2012 Prevention of Acquired Epilepsy Award</category>
						<guid isPermaLink="false">6DC8FAF9-78E3-B519-1E49D6EBD2FC0B9E</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Behavioral Sciences Post-Doctoral Fellowship</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline: March 1 Eligibility: Individuals who will have received their doctoral degrees in a field of the social sciences by the time the Fellowship commences, and desire additional postdoctoral research experience, may apply. Application Information: The Behavioral Sciences Post-Doctoral Fellowship develops excellent behavioral scientists to teach the appropriate psychosocial intervention techniques used in working with people with epilepsy, and contributes to the body of behavioral research in epilepsy. Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=14</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Behavioral Sciences Post-Doctoral Fellowship</category>
						<guid isPermaLink="false">6DC8FAFD-78E3-B519-1E49CCBA0455512C</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Behavioral Sciences Student Fellowship</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline: March 1 Eligibility: Both graduate and undergraduate students are eligible. Application Information: The Behavioral Sciences Student Fellowship stimulates individuals to pursue careers in epilepsy in either research or practice settings. Appropriate fields include sociology, social work, psychology, anthropology, nursing, economics, vocational rehabilitation, counseling, political science, and others relevant to epilepsy research or practice. Undergraduate and graduate level students are eligible. The $3,000 stipend is for conducting a 3-month summer project. Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=15</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Behavioral Sciences Student Fellowship</category>
						<guid isPermaLink="false">6DC8FB02-78E3-B519-1E494D910B3EC446</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Clinical Fellowship Award</title>
						
						<description><![CDATA[Sponsor: Tuberous Sclerosis Alliance Source: Tuberous Sclerosis Alliance Application Deadline: TBA Eligibility: Open to all investigators at established academic and/or research institutions worldwide. Researchers residing in the U.S.A. do not need to be U.S. citizens in order to apply. Application Information: Before submitting an application for research support, an applicant must submit a Letter of Intent (LOI) briefly describing the project.  If the research proposed in the LOI meets the TS Alliance&amp;apos;s funding priorites in a given year, the investigator will be invited to submit a formal proposal.  The TS Alliance Grant Review Committee carefully reveiws all LOIs submitted for reveiw.Deadline for Receipt of Letter of Intent: November 1, 2008Deadline for Receipt of Completed Application: February 1, 2009 Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=34</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Clinical Fellowship Award</category>
						<guid isPermaLink="false">6DC8FB07-78E3-B519-1E499A8B87BB160D</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Concept, Clinical Trial, Technology/Therapeutic Development and Investigator Initiated Research Awards</title>
						
						<description><![CDATA[Sponsor: Department of Defense Source: U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP) Application Deadline: null Eligibility: Brief descriptions of each of these award mechanisms are available on the Congressionally Directed Medical Research Programs website at http://cdmrp.army.mil/pubs/press/2010/10prmrppreann.htm.  Submission deadlines for the various programs appear below in Other Information. Term of award and grant amounts are available on the above mentioned web site. Application Information: The Fiscal Year 2010 (FY10) Defense Appropriations Act provides $50 million to the Department of Defense Peer Reviewed Medical Research Program (PRMRP) appropriation to provide support for military health-related research of exceptional scientific merit. This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP). A summary of PRMRP funding opportunities is provided below.  Detailed descriptions of each of the funding mechanisms, evaluation criteria, and submission requirements can be found in the FY10 PRMRP Program Announcements. Each Program Announcement is available electronically for downloading from the Grants.gov website (&amp;lt;http://www.grants.gov&amp;gt;), the CDMRP website (&amp;lt;http://cdmrp.army.mil/funding/prmrp.htm&amp;gt;) and the CDMRP eReceipt Website (https://cdmrp.org).A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. Other: Submission Deadlines:Concept AwardPre-Application Letter of Intent:  March 25, 2010Proposal:  April 8, 2010Clinical Trail AwardPre-Application Letter of Intent:  April 22, 2010Proposal:  May 13, 2010Technology/Therapeutic Development Award   Pre-Application Letter of Intent:  April 22, 2010Proposal:  May 13, 2010Investigator-Initiated Research AwardPre-Application Pre-Proposal:  March 11, 2010Proposal:  August 5, 2010]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=107</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Concept, Clinical Trial, Technology/Therapeutic Development and Investigator Initiated Research Awards</category>
						<guid isPermaLink="false">6DC8FB11-78E3-B519-1E495300D2914487</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Department of Defense Peer Reviewed Medical Research Program</title>
						
						<description><![CDATA[Sponsor: DOD Source: DOD Application Deadline: null Eligibility: Detailed descriptions of each of the funding opportunities, evaluation criteria, and submission requirements can be found in the FY11 PRMRP Program Announcements. Each Program Announcement is available electronically for downloading from the Grants.gov website (http://www.grants.gov ), the CDMRP website (http://cdmrp.army.mil/ ) and the CDMRP eReceipt System (https://cdmrp.org). Application Information: The Fiscal Year 2011 (FY11) Defense Appropriations Act provides $50M to the Department of Defense (DOD) Peer Reviewed Medical Research Program (PRMRP) to improve the health and well-being of all military service members, veterans, and beneficiaries. This program is administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) through the Office of the Congressionally Directed Medical Research Programs (CDMRP). Submission Deadlines: Clinical Trial AwardPre-Application:  June 28, 2011Application:  July 19, 2011 Discovery AwardPre-Application:  June 14, 2011Application:  July 5, 2011 Investigator Initiated Research Award (Partnering PI option)Pre-Application:  June 14, 2011Application:  July 5, 2011 Technology/Therapeutic Development AwardPre-Application:  June 14, 2011Application:  July 5, 2011 Other: Applications submitted to any of these funding opportunities will need to address one of the following topic areas.   Chronic fatigue syndromeChronic migraine and post-traumatic headacheDrug abuseEpidermolysis bullosaEpilepsyFragile X syndromeInflammatory bowel diseaseInterstitial cystitisListeria vaccine for infectious diseaseLupusNeuroblastomaOsteoporosis and related bone diseasePaget&amp;amp;#8217;s diseasePancreatitisPheochromocytomaPolycystic kidney diseasePosttraumatic osteoarthritisSclerodermaSocial work researchTinnitus]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=119</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Department of Defense Peer Reviewed Medical Research Program</category>
						<guid isPermaLink="false">6DC8FB1A-78E3-B519-1E49467904F9DD34</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Early Career Physician Scientist Award &amp; Susan Spencer Fellowship</title>
						
						<description><![CDATA[Sponsor: American Epilepsy Society Source: American Epilepsy Society Application Deadline: September 15 Eligibility: PROGRAM ON HOLD - NOT OPEN FOR APPLICATIONS AT THIS TIMEEarly Career Physician Scientists holding a Doctor of Medicine or equivalent degree; have completed a residency in neurology or neurosurgery; be not more than four years out of residency or fellowship training; hold a faculty appointment not higher than Assistant Professor; be committee to a career in translational reserach in epilepsy; and be working with a highly qualified mentor at an epilepsy center. Application Information: This program seeks to encourage the development of new therapies for epilepsy by providing research training for physicians early in their academic career.  These award are primarily for infestigators whose research interests will potentially affect epilepsy patients in the near term. There are no geographic restrictions.  Projects focusing on pregnancy and epilepsy are encouraged. Other: Applications will be reviewed on the basis of the applicant&amp;apos;s commitment to a research career, the training record of the mentor and epilepsy center and the quality and relevance of the research project for developing cures for epilepsy.  Number of awards to be determined]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=12</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Early Career Physician Scientist Award &amp; Susan Spencer Fellowship</category>
						<guid isPermaLink="false">6DC8FB20-78E3-B519-1E4929C79FC3E3EB</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Grass Fellowship Program</title>
						
						<description><![CDATA[Sponsor: Grass Foundation Source: Grass Foundation Application Deadline: null Eligibility: Applicants must be in the late stages of predoctoral training or be postdoctoral researchers.  Priority is given to applicants with a demonstrated commitment to a research career and no prior research experience at the Marine Biological Laboratory. Application Information: The Grass Foundation encourages independent research by investigators early in their careers and increases research opportunities for persons planning careers in neurobiological investigation.  Supported approaches include neurophysiology, biophysics, integrative neurobiology, neuroethology, neuroanatomy, neuropharmacology, systems neuroscience, cellular and developmental neurobiology and computational approaches to neural systems. Grass Fellowships at the Marine Biological Laboratory (MBL) support investigator=designed, independent research projects.  While sharing space in the Grass Lab, fellows function as an intellectual and social group within the MBL community. Other: The duration of the program is 14 weeks from 24 May to 30 August, 2009 at the Marine Biological Laboratory, Woods Hole, MA, USA.  Funds provided to support an investigator, spouse or domestic partner, and dependent children for one summer at the MBL in Woods Hole, Massachusetts, USA.  Laboratory research space, equipment, housing, board and round-trip travel expenses provided.For more information go to www.grassfoundation.org or contact Ann Woolford at awoolford@mbl.edu, (508) 289-7173.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=85</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Grass Fellowship Program</category>
						<guid isPermaLink="false">6DC8FB28-78E3-B519-1E49128407B3A976</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Grass Foundation/AES Robert S. Morison Fellowship</title>
						
						<description><![CDATA[Sponsor: AES/The Grass Foundation Source: The Epilepsy Foundation Application Deadline: September 1, 2007 Eligibility: This mechanism has been closed indefinitely.  This two year post doctoral fellowship will be awarded to a promising young investigator possessing an MD degree who intends to continue training in basic science in an epilepsy research laboratory. Application Information: This mechanism has been closed indefinitely.Please note in the application the desire to be considered for a Morison Fellowship. Physicians interested in being considered should apply for either a Postdoctoral Fellowship or a Research and Training Fellowship for Clinicians administered by the Epilepsy Foundation Other: The Morison Fellowship will be selected by the AES/EF Clinical Grant Selection Committee from among qualified applicants for the Postdoctoral Fellowships and Research and Training Fellowships. Applicants for this fellowship can at the same time be considered for a fellowship in the category under which he/she applied. The Fellowship will be $40,000 per year for two years for salary with an additional $10,000 (maximum) per year to be used for institutional fringe benefits plus $1,000 for the fellow to travel to the AES Annual Meeting to present his/her results.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=5</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Grass Foundation/AES Robert S. Morison Fellowship</category>
						<guid isPermaLink="false">6DC8FB2F-78E3-B519-1E497B01961D635F</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Health Sciences Student Fellowship</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline: March 1 Eligibility: Predoctoral training students in the Health Sciences may be accepted at any point in their schooling-following acceptance but before beginning the first year, or in the period immediately following their final year. Application Information: The Health Sciences Student Fellowship stimulates individuals to pursue careers in epilepsy in either research or practice settings. Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=16</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Health Sciences Student Fellowship</category>
						<guid isPermaLink="false">6DC8FB32-78E3-B519-1E499D423CCEA1F8</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Lennox &amp; Lombroso Postdoctoral Research Fellowship</title>
						
						<description><![CDATA[Sponsor: AES / Lennox &amp;amp; Lombroso Fund for Research &amp;amp; Training Source: Epilepsy Foundation Application Deadline: null Eligibility: Physicians or Ph.D. neuroscientists who desire postdoctoral research experience are eligible to apply. Application Information: Apply for the Postdoctoral Research Training Fellowship. The Postdoctoral Research Fellowship develops academic physicians and scientists committed to research related to epilepsy. Applications are considered equally from individuals interested in acquiring experience either in basic laboratory research or in the conduct of human clinical studies. Other: Funded every other year, in odd numbered years.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=116</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Lennox &amp; Lombroso Postdoctoral Research Fellowship</category>
						<guid isPermaLink="false">6DC8FB37-78E3-B519-1E49C7C11E43A1C8</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Lennox &amp; Lombroso Pre-doctoral Research &amp; Training Fellowship</title>
						
						<description><![CDATA[Sponsor: AES / Lennox &amp;amp; Lombroso Fund for Research &amp;amp; Training Source: Epilepsy Foundation Application Deadline: null Eligibility: Graduate students must be matriculating in a full-time doctoral (Ph.D.) program with an academic career focus. Application Information: Apply for the Predoctoral Research Training Fellowship.  The Predoctoral Research Training Fellowship supports pre-doctoral students with dissertation research related to epilepsy, thus strengthening their interest in establishing epilepsy research as a career direction. Other: Fellowship offered every year]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=117</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Lennox &amp; Lombroso Pre-doctoral Research &amp; Training Fellowship</category>
						<guid isPermaLink="false">6DC8FB3B-78E3-B519-1E49BCAD38EBB55A</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Nationial EpiFellows Research Grants</title>
						
						<description><![CDATA[Sponsor: Pfizer, Inc. Source: National EpiFellows Foundation Application Deadline:  Eligibility: The applicant must hold an MD degree or the equivalent, have completed residency training or be in their final year, have no more than 3 years of post-residency experience, and be in or accepted to a formal Epilepsy fellowship. It is expected that the candidates will have some clinical duties in addition to research activities. The applicant must be sponsored by a full-time faculty member of a university medical school or research institution, with the recommendation of the sponsor and the director of the Epilepsy Fellowship. Application Information: Applications and guidelines can be accessed at www.epifellows.com.  Questions can be directed to National EpiFellows Foundatoin at 1-800-288-2074. Other: Up to five grants will be given.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=71</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Nationial EpiFellows Research Grants</category>
						<guid isPermaLink="false">6DC8FB40-78E3-B519-1E49E05FEA903EEE</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>New Therapy Grants Program</title>
						
						<description><![CDATA[Sponsor: Epilepsy Therapy Project and Epilepsy Foundation Source: Epilepsy Therapy Project Application Deadline: March 15 Eligibility: The New Therapy Grants Program provides grants supporting the research and development of new therapies for epilepsy in both the academic and commercial settings worldwide to scientific and clinical investigators pursuing innovative, high impact projects that demonstrate a clear path to commercialization from the lab to the patient.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;All proposals must demostrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development.  &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Preference will be given to proposals that already have a commercial partner engaged to assist with development and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source. Application Information: For details go to the above web site or contact grants@epilepsytherapyproject.org &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;LETTER OF INTENT IS DUE MARCH 2, 2011 BY 11:59 PM ET. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;FULL PROPOSAL IS DUE APRIL 13, 2011 BY 11:59 PM ET.  &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;FULL PROPOSALS WILL BE ACCEPTED ONLY FROM INVESTIGATORS WHOSE LETTER OF INTENT WAS APPROVED.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The New Therapy Grants Program seeks to advance the development of specific new therapies including but not limited to medicines and devices.  Consistent with the theme of translational research, all grant proposals must demonstrate a clear path from the lab to the patient and are evaulated for their potential value to patients, likelihood of successful development including regulatory approval and timeframe of development.  Other areas of consideration include:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;1. Seed funding for targeted work necessary to explore novel therapeutic approaches &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;2. Projects which if successful would be likely to support further development &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;3. Proposals that support the commercialization of exceptional academic research &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;4. Proposals seeking to develop new therapies for children &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;5. Proposals addressing SUDEP (Sudden Unexplained Death in Epilepsy) &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Preference will be given to proposals that already have a commercial partner engaged to assist with development and to proposals that have committed or matched funding from the sponsoring institution, commercial partner or other third party source.  &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Proposals for research originating from outside the United States are welcome.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;INVESTIGATORS MUST SUBMIT A LETTER OF INTENT (LOI) BY MARCH 2, 2011 BY 11:59 PM ET.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;THE DEADLINE FOR RECEIPT OF *FULL PROPOSAL IS APRIL 13, 2010 BY 11:59 PM ET.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;*FULL PROPOSALS WILL BE ACCEPTED ONLY FROM INVESTIGATORS WHOSE LETTER OF INTENT WAS APPROVED.* Other: The New Therapy Grants Program is a unique partnership between two leading non-profit organizations, the Epilepsy Therapy Project and the Epilepsy Foundation.  The New Therapy Grants Program seeks to advance the development of new therapies for epilepsy, acclerating the advancement of research from the laboratory to the patient.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=28</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>New Therapy Grants Program</category>
						<guid isPermaLink="false">6DC8FB4E-78E3-B519-1E497D5B65497D2D</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-050 Small Business Innovation Research Grant (Parent SBIR [R43/R44])</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: On an SBIR application, the Project Director/Principal Investigator (PD/PI) must have his/her primary employment (more than 50%) with the SBC at the time of award and for the duration of the project.  Only United States small business concerns (SBCs) are eligible to submit SBIR applications. See announcement for more details. Application Information: This Funding Opportunity Announcement (FOA) issued by the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC) the Food and Drug Administration (FDA), and the Administration for Children and Families (ACF) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Fast-Track (NIH only), and Phase II Competing Renewal (NIH only) grant applications. The PHS 2010-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, FDA, and ACF represent scientific program areas that may be of interest to applicant SBCs in the development of projects that have potential for commercialization.This funding opportunity will use the R43/R44 award mechanisms.Check out other opportunities at NINDS Grant Mechanisms: http://www.ninds.nih.gov/funding/grant_mechanisms.htmNINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Randall Stewart, Ph.D.Program Director, Extramural Research ProgramNIH/NINDSrs416y@nih.gov301-496-1917]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=60</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-050 Small Business Innovation Research Grant (Parent SBIR [R43/R44])</category>
						<guid isPermaLink="false">6DC8FB55-78E3-B519-1E496906C912D711</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-051 Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: On an STTR application, the PD/PI may be employed with the SBC or the participating non-profit research institution as long as he/she has a formal appointment with or commitment to the applicant SBC, which is characterized by an official relationship between the small business concern and that individual Application Information: This Funding Opportunity Announcement (FOA) issued by the National Institutes of Health (NIH) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R&amp;amp;D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see PHS 2010-2 SBIR/STTR Program Descriptions and Research Topics for NIH.) NIH Small Business Program Informationhttp://grants.nih.gov/grants/funding/sbir.htmNINDS Small Business Program Informationhttp://www.ninds.nih.gov/funding/small-business/index.htm Other: Randall Stewart, PhD301-496-1917stewartr@ninds.nih.govChristina Vert, MS301-496-1917vertc@ninds.nih.govStephanie Fertig, MBA301-496-1447sf260n@nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=81</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-051 Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])</category>
						<guid isPermaLink="false">6DC8FB5C-78E3-B519-1E49D8F386794F45</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-056 (K01) Career Development to Promote Re-entry</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Candidates for this award must have a research or health-professional doctoral degree. Candidates must be able to commit a minimum of 9 person-months (75% of full-time professional effort) conducting research career development activities associated with this award.  The remaining 3 months (25% effort) can be divided among other research, clinical, and teaching activities only if these activities are consistent with the goals of the K01 award, i.e., the candidate&amp;amp;#8217;s development into an independent investigator. Application Information: The NINDS program for Re-Entry Into the Neurological Sciences (RENS) assists basic and clinical neurological scientists re-enter active careers in science and academic medicine related to neurological sciences. The program is designed for individuals who have experienced an interruption in their research careers in neurological science. Applicants must demonstrate potential for a career as an independent investigator in basic or clinical research in the neurological sciences following a period of sponsored research support (up to 4 years). The candidate must have a doctoral degree in a basic or clinical area of neurological science, and at least 2 years of postdoctoral research experience in basic and/or clinical neurological science. The candidate must have interrupted his or her career in neurological science for a period of at least 3 years but not more than 8 years. Examples of appropriate interruptions would include starting and/or raising a family, an incapacitating illness or injury, pursuing non-research endeavors that would permit earlier retirement of debt incurred in obtaining a doctoral degree, or performing military service. A minimum of 75% effort must be devoted to the program.Salary and Research Costs: NINDS will provide up to $85,000 of the awardees salary per year, and up to $50,000 per year toward research costs. Other: Stephen Korn, Ph.D.Training Office6001 Executive Blvd, Room 2186Bethesda, MD 20892Phone: (301) 496-4188Email: korns@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=113</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-056 (K01) Career Development to Promote Re-entry</category>
						<guid isPermaLink="false">6DC8FB67-78E3-B519-1E49EFEF88D7D823</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-057  (K02) Independent Scientist Award</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: Candidates for this award must have a doctoral degree.Level of Effort: Candidates must be able to commit a minimum of 9 person-months (75% of full-time professional effort) conducting research career development activities associated with this award. The remaining 3 months (25% effort) can be divided among other research, clinical, and teaching activities only if these activities are consistent with the goals of the K02 award, i.e., the candidate&amp;amp;#8217;s development into an independent investigator. For information regarding NIH policy on determining full-time professional effort for career awards, see NOT-OD-04-056. At the time of award, the candidate must have a &amp;amp;#8220;full-time&amp;amp;#8221; appointment at the academic institution that is the applicant institution. Candidates who have VA appointments may not consider part of the VA effort toward satisfying the &amp;amp;#8220;full time&amp;amp;#8221; requirement at the applicant institution. Candidates with VA appointments should contact the staff person in the relevant Institute or Center prior to preparing an application to discuss their eligibility. Application Information: The intent of the Independent Scientist Award (K02) is to support health professionals who are committed to a career in neuroscience research and who have recently achieved independent scientist status. This program normally follows a K08 or K23 award and supports the continued career development of independent clinician-scientists so that they can be more successful in obtaining an R01 or equivalent grant. The award provides salary and research costs for the first three years, and continued salary support for years four and five, with the last two years of support contingent on successful competition for an R01 or equivalent award. In contrast to requirements of other institutes, applicants are not eligible for this award if they have a major, independent, peer-reviewed research grant (R01, subproject on a P01, or equivalent) prior to receiving the K02 award.  Awardees are encouraged to apply for R01 support at any time after they&amp;amp;#8217;ve received the K02 award. The K02 is intended for physician-scientists who are missing one or more components that would make them competitive for an R01, so applicants should not submit an R01 application simultaneously with a K02 application. The candidates must hold a clinical doctoral degree, have completed postgraduate clinical training prior to application, and hold a primary appointment in a clinical department. The candidate must also devote a minimum of 75% effort to the proposed award activities. Special Note: To accommodate neurosurgeons, who need significant clinical activity to maintain their surgical skills, NINDS will accept 50% time commitment to the award.Salary and Research Costs: Salary and Research Costs: In years 1 - 3 of the K02 award, NINDS will provide up to $95,000 of the awardee&amp;apos;s salary per year, plus the applicable fringe benefit rate, plus up to $50,000 per year toward research costs. Once an applicant receives an R01 or equivalent award, the applicant may obtain up to 80% of their institutional base salary from the K02, commensurate with their effort on the K02. Once an R01 or equivalent is obtained, research costs will no longer be provided through the K02 award.Institutional Support: Please pay careful attention to specific issues that must be addressed in a statement of institutional support for the K02. http://www.ninds.nih.gov/funding/institutional_support_k02_awards.htm Other: Brandy E Fureman, PhDProgram Director, Extramural Research ProgramNIH/NINDSNeuroscience Center, Room  21386001 Executive Blvd MSC 9523Bethesda, MD 20892-9523furemanb@ninds.nih.gov301-496-1917]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=63</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-057  (K02) Independent Scientist Award</category>
						<guid isPermaLink="false">6DC8FB76-78E3-B519-1E490E4ED209DE8D</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-059 (K08) Mentored Clinical Scientist Development Award</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: This program is intended to support applicants with a clinical doctoral degree that are within 3 years of completing their clinical training (which is defined as sequential years of residency training and clinical fellowships).  Applicants that are beyond 3 years post clinical training must obtain prior written approval from the NINDS Director of Training and Career Development to be eligible for this program.  Candidates must be able to commit a minimum of 9 person-months (75% of full-time professional effort) conducting research career development activities associated with this award.  The remaining 3 months (25% effort) can be divided among other research, clinical, and teaching activities only if these activities are consistent with the goals of an NIH K08 Award, i.e., the candidate&amp;amp;#8217;s development into an independent investigator. Application Information: The Mentored Clinical Scientist Development Award (K08) is designed to provide &amp;quot;protected time&amp;quot; for clinically trained individuals to participate in an intensive, supervised training program in biomedical research, including translational research, related to neurological disorders.  Although the award is primarily targeted to candidates holding an MD or equivalent degree, it may also support individuals holding other health professional degrees. The award supports a 3-5 year period of supervised basic or clinical neuroscience research experience and should be comparable in scope and rigor to meeting the requirements for an advanced research degree.  The candidate must identify a mentor with extensive research experience and must devote a minimum of 75% of his or her time and effort to the proposed research and career development activities.Special Note: To accommodate neurosurgeons, who need significant clinical activity to maintain their surgical skills, NINDS will accept 50% time commitment to the award.Salary and Research Costs: NINDS will provide up to $85,000 of the awardees salary per year, and up to $50,000 per year toward research costs.Institutional Support: Please pay careful attention to specific issues that must be addressed in a statement of institutional support for K08 and K23 awards.  http://www.ninds.nih.gov/funding/institutional_support_mentored_k_awards.htm Other: Brandy E Fureman, PhDProgram Director, Extramural Research Program,NIH/NINDS,Neuroscience Center, Room  2138,6001 Executive Blvd, MSC 9523,Bethesda, MD 20892-9523,furemanb@ninds.nih.gov,301-496-1917Stephen Korn, Ph.D.Training and Career Development Office6001 Executive Blvd, Room 2186Bethesda, MD 20892Phone: (301) 496-4188Email: korns@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=64</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-059 (K08) Mentored Clinical Scientist Development Award</category>
						<guid isPermaLink="false">6DC8FB82-78E3-B519-1E49ED1447517547</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-060 (K23) Mentored Patient-Oriented Research Career Development Award</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: Candidates for this award must have a health-professional doctoral degree.  Candidates must be able to commit a minimum of 9 person-months (75% of full-time professional effort) conducting research career development activities associated with this award.  The remaining 3 months (25% effort) can be divided among other research, clinical, and teaching activities only if these activities are consistent with the goals of an NIH K23 Award, i.e., the candidate&amp;amp;#8217;s development into an independent investigator.  At the time of award, the candidate must have a &amp;amp;#8220;full-time&amp;amp;#8221; appointment at the academic institution that is the applicant institution. Application Information: The Mentored Patient-Oriented Research Career Development Award (K23) was created to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research. For the purposes of this award, patient-oriented research is defined as research conducted with human subjects (or on material of human origin such as tissues, specimens, and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: 1) mechanisms of human disease; 2) therapeutic interventions; 3) clinical trials; and 4) the development of new technologies. This mechanism provides support for a period of supervised study and research for clinically trained professionals (MD or equivalent) who have the potential to develop into productive clinical investigators focusing on patient-oriented research. The project period may be 3-5 years. Candidates must devote a minimum of 75% of full-time professional effort in research career development and clinical research activities.Special Note: To accommodate neurosurgeons, who need significant clinical activity to maintain their surgical skills, NINDS will accept 50% time commitment to the award.Salary and Research Costs: : NINDS will provide up to $85,000 of the awardees salary per year, and up to $50,000 per year toward research costs. K23 award recipients are encouraged to apply for independent research awards while the K award is active, and should consult with the NINDS Director of Training and Career Development for budget guidance in this process. For important information regarding salary support from mentored K awards when applicants receive a concurrent R01, refer to notice NOT-NS-09-015.Institutional Support: Please pay careful attention to specific issues that must be addressed in a statement of institutional support for K08 and K23 awards.  http://www.ninds.nih.gov/funding/institutional_support_mentored_k_awards.htm Other: Brandy E Fureman, PhDProgram Director, Extramural Research ProgramNIH/NINDSNeuroscience Center, Room  21386001 Executive Blvd MSC 9523Bethesda, MD 20892-9523furemanb@ninds.nih.gov301-496-1917Stephen KornDirector of NINDS Training and Career Development National Institute of Neurological Disorders and Stroke6001 Executive Boulevard, Room 2186, MSC 9531Bethesda, MD 20892 (for courier: Rockville, MD 20852)Phone: (301) 496-4188Email: NINDSTrainingOffice@ninds.nih.gov  or korns@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=66</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-060 (K23) Mentored Patient-Oriented Research Career Development Award</category>
						<guid isPermaLink="false">6DC8FB90-78E3-B519-1E499324B3B50958</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-061 (K24) Midcareer Investigator Award in Patient-Oriented Research</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Candidates for this award must have a health-professional doctoral degree or its equivalent. Candidates should typically be in the midcareer stage at the Associate Professor level or functioning at that rank in an academic setting or equivalent non-academic setting and must have an established record of independent, peer-reviewed patient-oriented research grant funding including at the time of application and record of publications. This award is intended for individuals who have a record of supervising and mentoring patient-oriented researchers. A K24 award recipient who is promoted to Full professor, but continues to have an independent peer-reviewed patient-oriented research program and provides mentoring to new investigators, may continue to be supported through the K24 program. Candidates are advised to discuss their eligibility with the NINDS Training Office.  Candidates must be able to demonstrate the need for protected time, 3-6 person months (25-50% of full-time professional effort) for a period of intensive research focus as a means of augmenting their capabilities in POR and act as a mentor to new clinical investigators in the conduct of POR during this period. Candidates for the K24 award may not have pending peer review or concurrently apply for any other PHS career award. Application Information: Submission dates: Feb 12, June 12, Oct 12Expiration Date: January 8, 2013The Midcareer Investigator Award in Patient-Oriented Research (K24) at NINDS provides support for clinician-scientists to expand their research and, more importantly, to act as mentors for junior clinician investigators. The target candidates are outstanding, mid-career clinician scientists with productive, well-funded research programs and significant mentoring experience. At least a portion of the awardee&amp;amp;#8217;s research must be patient-oriented to qualify for the NIH K24. The project period may be up to 5 years, and awards are renewable if the candidate still meets the stated requirements. Candidates for this award must have a clinical degree (e.g., MD or equivalent), and must devote between 25-50% effort to the activities associated with this award. Applicants must have significant independent research support at the time of application for this program, and are expected to have NIH R01 or equivalent funding for at least 3 out of 5 years of K24 support. Mentoring programs must include a larger population than that associated with the awardee&amp;amp;#8217;s research program. Other: Stephen KornDirector of NINDS Training and Career Development National Institute of Neurological Disorders and Stroke6001 Executive Boulevard, Room 2186, MSC 9531Bethesda, MD 20892 (for courier: Rockville, MD 20852)Phone: (301) 496-4188Email: NINDSTrainingOffice@ninds.nih.gov  or korns@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=99</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-061 (K24) Midcareer Investigator Award in Patient-Oriented Research</category>
						<guid isPermaLink="false">6DC8FB9C-78E3-B519-1E49A9885EE4C427</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-063 (K99/R00) NIH Pathway to Independence Award</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: Eligible candidates will have no more than 5 years of postdoctoral research at the time of application (initial or amended). In addition, eligible applicants will currently be in a mentored postdoctoral position, regardless of title. See announcement eligibility section for more details. Application Information: The Pathway to Independence Award is uniquely designed to facilitate the transition of outstanding postdoctoral candidates from mentored to independent research positions. The award contains two components, a mentored (K99) phase that can last up to 2 years and an independent (R00) phase, which will have a duration of 3 years. The objective of the program is to facilitate research independence earlier in an investigator&amp;apos;s career. Investigators complete supervised research, and apply for an independent research faculty position, during the mentored phase of the award. Activation of the independent award phase is administrative, and is contingent upon the investigator securing an independent research position. Eligible candidates will have no more than 5 years of postdoctoral research at the time of application (initial or amended). In addition, eligible applicants will currently be in a mentored postdoctoral position, regardless of title.  Review the NIH definition of a postdoctoral scholar.  Award recipients are expected to obtain R01 support during the independent phase of the award.Special Note: To accommodate neurosurgeons, who need significant clinical activity to maintain their surgical skills, NINDS will accept 50% time commitment to the award.Salary and Research Costs: For mentored candidates in an extramural institution, NINDS will provide up to $50,000 per year for salary support (up to $85,000 per year for applicants with an M.D. degree), plus fringe, and up to $20,000 for research support costs. Budget details for mentored candidates in the NIH intramural program will be negotiated with the sponsoring laboratory and will be consistent with offers to scientists in comparable positions. Applicants must complete budget fields for both phases of the award in order to successfully submit an application. It is expected that the budget for the independent (R00) phase will be unknown at the time of submission. Applicants can simply enter $249,000 in total costs.http://www.ninds.nih.gov/funding/postdoc.htm#k99 Other: Stephen Korn. Ph.D., Director of Training and Career Development,National Institute of Neurological Disorders and Stroke (NINDS), 6001 Executive Blvd , Room 2186, Bethesda , MD 20892, Phone: (301) 496-4188, Fax: (301) 594-5929, korns@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=73</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-063 (K99/R00) NIH Pathway to Independence Award</category>
						<guid isPermaLink="false">6DC8FBA9-78E3-B519-1E49B3ECFC7811AC</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-067 (R01) Research Project Grant</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. More than one PD/PI (i.e., multiple PDs/PIs), may be designated on the application for projects that require a &amp;amp;#8220;team science&amp;amp;#8221; approach and therefore clearly do not fit the single-PD/PI model. Additional information on the implementation plans and policies and procedures to formally allow more than one PD/PI on individual research projects is available at http://grants.nih.gov/grants/multi_pi. Application Information: The Research Project Grant (R01) is an award to support a discrete, specified, circumscribed project to be performed by named Project Directors/Principal Investigators (PDs/PIs) in areas representing the investigators&amp;amp;#8217; specific interests and competencies, based on the mission of the NIH. The R01 is the original and historically the oldest grant mechanism used by the NIH to support health-related research and development.The NIH awards R01 grants to institutions/organizations of all types. This mechanism allows the PDs/PIs to define the scientific focus or objective of the research based on particular areas of interest and competence. Although the PDs/PIs write the grant application and are responsible for conducting and supervising the research, the actual applicant is the research institution/organization.Research grant applications are assigned to an NIH IC based on receipt and referral guidelines and many applications are assigned to multiple ICs with related research interests.Each IC maintains a Web site with funding opportunities and areas of interest. Contact with an IC representative may help focus the research plan based on an understanding of the mission of the IC. For specific information about the mission of each NIH IC, see http://www.nih.gov/icd, which provides a brief summary of the research interests in each IC and access to individual IC home pages.Check out other NINDS funding opportunities:http://www.ninds.nih.gov/funding/funding_announcements/funding_opps.htmCheck out other funding grant mechanisms: http://www.ninds.nih.gov/funding/grant_mechanisms.htmNINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Brandy E Fureman, PhDProgram Director, Extramural Research Program,NIH/NINDS,Neuroscience Center, Room  2138,6001 Executive Blvd, MSC 9523,Bethesda, MD 20892-9523,furemanb@ninds.nih.gov,301-496-1917]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=57</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-067 (R01) Research Project Grant</category>
						<guid isPermaLink="false">6DC8FBB5-78E3-B519-1E4992C1CD6DA9C9</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-069 (R21) NIH Exploratory/Developmental Research Grant Program</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. More than one PD/PI (i.e., multiple PDs/PIs), may be designated on the application for projects that require a &amp;amp;#8220;team science&amp;amp;#8221; approach and therefore clearly do not fit the single-PD/PI model. Additional information on the implementation plans and policies and procedures to formally allow more than one PD/PI on individual research projects is available at http://grants.nih.gov/grants/multi_pi. All PDs/PIs must be registered in the NIH electronic Research Administration (eRA) Commons prior to the submission of the application (see http://era.nih.gov/ElectronicReceipt/preparing.htm for instructions).The decision of whether to apply for a grant with a single PD/PI or multiple PDs/PIs is the responsibility of the investigators and applicant organizations and should be determined by the scientific goals of the project. Applications for grants with multiple PDs/PIs will require additional information, as outlined in the instructions below. When considering the multiple PD/PI option, please be aware that the structure and governance of the PD/PI leadership team as well as the knowledge, skills and experience of the individual PDs/PIs will be factored into the assessment of the overall scientific merit of the application. Multiple PDs/PIs on a project share the authority and responsibility for leading and directing the project, intellectually and logistically. Each PD/PI is responsible and accountable to the grantee organization, or, as appropriate, to a collaborating organization, for the proper conduct of the project or program, including the submission of required reports. For further information on multiple PDs/PIs, please see http://grants.nih.gov/grants/multi_pi. Application Information: The evolution and vitality of the biomedical sciences require a constant infusion of new ideas, techniques, and points of view. These may differ substantially from current thinking or practice and may not yet be supported by substantial preliminary data. By using the R21 mechanism, the NIH seeks to foster the introduction of novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research.  The R21 mechanism is intended to encourage new exploratory and developmental research projects. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research.  Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.Applications for R21 awards should describe projects distinct from those supported through the traditional R01 mechanism. For example, long-term projects, or projects designed to increase knowledge in a well-established area, will not be considered for R21 awards. Applications submitted under this mechanism should be exploratory and novel. These studies should break new ground or extend previous discoveries toward new directions or applications. This funding opportunity will use the R21 award mechanism.For NINDS specific R21 requirements go to this website: http://www.ninds.nih.gov/funding/r21guidelines.htmCheck out other opportunities at NINDS Grant Mechanisms: http://www.ninds.nih.gov/funding/grant_mechanisms.htmNINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Brandy E Fureman, PhDProgram Director, Extramural Research ProgramNIH/NINDSNeuroscience Center, Room  21386001 Executive Blvd MSC 9523Bethesda, MD 20892-9523furemanb@ninds.nih.gov301-496-1917]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=59</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-069 (R21) NIH Exploratory/Developmental Research Grant Program</category>
						<guid isPermaLink="false">6DC8FBC6-78E3-B519-1E496820AE6B3D83</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-070 (R15) Academic Research Enhancement Award (AREA)</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Scientists working in AREA-eligible minority or women&amp;apos;s educational institutions are also encouraged to participate in this program.However, applicants:May not be the Project Director/Principal Investigator (PD/PI) of any active NIH research grant, including another AREA grant, at the time of award of an AREA grant (although he or she may be one of the project personnel for an active NIH grant held by another PD/PI). May not be awarded more than one AREA grant at a time (although he or she may hold successive new or competing renewal AREA grants). May not submit an application to NIH for another research grant for essentially the same project proposed in a pending AREA application (in accordance with the general NIH prohibition against the submission in the same review cycle of more than one application for the same work).  The applicant organization must offer baccalaureate or advanced degrees in the sciences related to biomedical and behavioral and meet the requirement of receiving research grants and/or cooperative agreements from the NIH totaling not more than $6 million per year (in both direct and F&amp;amp;A/indirect costs) in each of four (4) or more of the last seven (7) years.  The applicant organization must be a &amp;amp;#8220;Health professional school/college&amp;amp;#8221; or &amp;amp;#8220;other academic component&amp;amp;#8221; at a university/college.See announcement link for more details. Application Information: The National Institutes of Health (NIH) is continuing to make a special effort to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation&amp;apos;s research scientists, but that have not been major recipients of NIH support.  Since Fiscal Year (FY) 1985, Congressional appropriations for the NIH have included funds for this initiative, which NIH has implemented through the Academic Research Enhancement Award (AREA) program.  Based on the expectation that funds will continue to be available each year, the NIH invites applications for AREA grants (R15) through a standing, ongoing Funding Opportunity Announcement (FOA).  AREA funds are intended to support new (&amp;quot;type 1&amp;quot;) and renewal (&amp;quot;type 2&amp;quot;) biomedical, behavioral or clinical research projects proposed by faculty members of eligible colleges, universities, schools, and components of domestic institutions.  The AREA program will enable qualified scientists to receive support for small-scale research projects.  These grants are intended to create a research opportunity for scientists and institutions otherwise unlikely to participate extensively in NIH programs to support the Nation&amp;apos;s biomedical and behavioral research effort.  It is anticipated that investigators supported under the AREA program will benefit from the opportunity to conduct independent research; that the grantee institution will benefit from a research environment strengthened through AREA grants and furthered by participation in the diverse extramural programs of the NIH; and that available students will benefit from exposure to and participation in scientific research in the biomedical, behavioral and clinical sciences.The AREA program is a research grant program and not a training or fellowship program.  Active involvement of undergraduate and graduate students in the proposed research is encouraged, and reviewers will consider whether the proposed project will expose undergraduate (preferably, if available) and graduate students to meritorious research.  However, the application should not focus on training objectives and training plans should not be provided. This funding opportunity will use the R15 award mechanism.Check out other opportunities at NINDS Grant Mechanisms: http://www.ninds.nih.gov/funding/grant_mechanisms.htmNINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Randall Stewart, PhDNINDSRoom 21356001 Executive BlvdBethesda, MD 20892301-496-1917stewartr@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=58</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-070 (R15) Academic Research Enhancement Award (AREA)</category>
						<guid isPermaLink="false">6DC8FBD8-78E3-B519-1E49AEE3E6227BD9</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-108 (F31) Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: This program will provide predoctoral training support for doctoral candidates who are within their first 6 years of graduate school, have or will have successfully completed their comprehensive examinations or the equivalent by the time of award, and will be performing dissertation research and training. Application Information: NINDS provides National Research Service Award (NRSA) predoctoral training fellowships (F31) to promising applicants with the potential to become productive, independent investigators in the scientific mission areas of the Institute. NINDS uses this mechanism to support the career development of neuroscientists (some rare exceptions apply), so the applicant must propose dissertation research in an area within the scientific mission of the NINDS and a training program appropriate for a career in neuroscience research. The mentor should be committed to the successful transition of the applicant to a subsequent appropriate position, have a strong track record in training, and have an active, funded research program in the area of the applicant&amp;apos;s proposed research. Potential applicants are strongly encouraged to contact the NINDS Training Office before preparation of an application to determine whether their proposed training and research falls within the NINDS mission.  Support will be provided for a maximum of 3 years. The applicant should provide evidence of potential for a productive research career based upon the quality of previous research training and academic record. The research training program should be carried out in a research environment that includes appropriate human and technical resources and is demonstrably committed to the research training of the applicant in the program he/she proposes in the application. Check out the NINDS Training and Career Development Office Web:http://www.ninds.nih.gov/funding/areas/training_and_career_development/index.htmCheck out other opportunities at NINDS Grant Mechanisms: http://www.ninds.nih.gov/funding/grant_mechanisms.htmCheck out the NINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Stephen Korn, Ph.D.Director of NINDS Training and Career Development National Institute of Neurological Disorders and Stroke6001 Executive Boulevard, Room 2186, MSC 9531Bethesda, MD 20892 (for courier: Rockville, MD 20852)Phone: (301) 496-4188Email: NINDSTrainingOffice@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=61</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-108 (F31) Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows</category>
						<guid isPermaLink="false">6DC8FBE4-78E3-B519-1E4918F04E5CF1EC</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-109 (F31) Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships to Promote Diversity in Health-Related Research</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Individuals from racial and ethnic groups that have been shown by the National Science Foundation to be underrepresented in health-related sciences on a national basis (see http://www.nsf.gov/statistics/showpub.cfm?TopID=2&amp;amp;SubID=27). In addition, it is recognized that under-representation can vary from setting to setting and individuals from racial or ethnic groups that can be convincingly demonstrated to be underrepresented by the grantee institution are eligible for support under this program. B.    Individuals with disabilities, who are defined as those with a physical or mental impairment that substantially limits one or more major life activities. C.    Individuals from disadvantaged backgrounds, who are defined as: 1.     Individuals who come from a family with an annual income below established low-income thresholds. These thresholds are based on family size; published by the U.S. Bureau of the Census; adjusted annually for changes in the Consumer Price Index; and adjusted by the Secretary for use in all health professions programs. The Secretary periodically publishes these income levels at http://aspe.hhs.gov/poverty/index.shtml. For individuals from low income backgrounds, the institution must be able to demonstrate that such candidates have qualified for Federal disadvantaged assistance or they have received any of the following student loans: Health Professions Student Loans (HPSL), Loans for Disadvantaged Student Program, or they have received scholarships from the U.S. Department of Health and Human Services under the Scholarship for Individuals with Exceptional Financial Need.2.     Individuals who come from a social, cultural, or educational environment such as that found in certain rural or inner-city environments that have demonstrably and recently directly inhibited the individual from obtaining the knowledge, skills, and abilities necessary to develop and participate in a research career. Eligibility related to a disadvantaged background (C1 and C2) is most applicable to high school and perhaps to undergraduate candidates, but would be more difficult to justify for individuals beyond that level of academic achievement. Under extraordinary circumstances the PHS may, at its discretion, consider an individual beyond the undergraduate level to be from a disadvantaged background.  Such decisions will be made on a case-by-case basis, based on appropriate documentation. Application Information: NINDS provides National Research Service Award (NRSA) training fellowships to outstanding predoctoral candidates from groups that have been shown to be underrepresented, including underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds.  The intent of this program is to increase the number of scientists from underrepresented populations in biomedical research.  Award recipients will receive up to five years of research training leading to a PhD. or equivalent research degree, a combined MD-PhD. degree, or another formally combined professional and research doctoral degree in biomedical, behavioral, health services, or clinical sciences.  Support is NOT available for individuals enrolled in medical or other professional schools UNLESS they are enrolled in a combined professional doctorate/PhD degree program in biomedical or behavioral research. Other: Michelle Jones-LondonProgram Director, OMHR, OD, NINDSNIH/NINDSNeuroscience Center, Room  21496001 Executive Blvd MSC 9535Bethesda, MD 20892-9535jonesmiche@ninds.nih.govStephen KornDirector of NINDS Training and Career Development National Institute of Neurological Disorders and Stroke6001 Executive Boulevard, Room 2186, MSC 9531Bethesda, MD 20892 (for courier: Rockville, MD 20852)Phone: (301) 496-4188Email: NINDSTrainingOffice@ninds.nih.gov  or korns@ninds.nih.govMargaret Jacobs, Program Director, Epilepsy Research, Channels, Synapses, and Circuits Cluster, National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Health (NIH), Neuroscience Center, Room 2138, 6001 Executive Blvd, Bethesda, MD  20892-9523, 301-496-1917, mj220@nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=94</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-109 (F31) Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships to Promote Diversity in Health-Related Research</category>
						<guid isPermaLink="false">6DC8FBF5-78E3-B519-1E49DB3DAA373F66</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-110 (F32) Ruth L. Kirschstein National Research Service Awards for Individual Postdoctoral Fellows</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Citizenship: By the time of award, the individual applicant must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status). Non-citizen nationals are generally persons born in outlying possessions of the United States (i.e., American Samoa and Swains Island). Individuals on temporary or student visas are not eligible. Individuals may apply for the award in advance of admission to the United States as a Permanent Resident recognizing that no award will be made until legal verification of Permanent Resident status is provided.Degree Requirements: Before a Ruth L. Kirschstein-NRSA postdoctoral fellowship award can be activated, the individual must have received a PhD, MD, DO, DC, DDS, DVM, OD, DPM, ScD, EngD, Dr PH, DNSc, ND (Doctor of Naturopathy), PharmD, DSW, PsyD, or equivalent doctoral degree from an accredited domestic or foreign institution (it is the responsibility of the sponsoring institution to determine if a foreign doctoral degree is equivalent). Certification by an authorized official of the degree-granting institution that all degree requirements have been met is also acceptable. A Ruth L. Kirschstein-NRSA fellowship may not be used to support studies leading to the MD, DO, DDS, DVM, or other similar health-professional degrees. Neither may these awards be used to support the clinical years of residency training. However, these awards are appropriate for the research fellowship years of a research-track residency program Application Information: The objective of NIH-supported Ruth L. Kirschstein National Research Service Awards programs is to help ensure that a diverse pool of highly trained scientists are available in adequate numbers and in appropriate research areas to address the Nation&amp;apos;s biomedical, behavioral, and clinical research needs.The purpose of the postdoctoral fellowship (F32) award is to provide support to promising postdoctoral applicants who have the potential to become productive and successful independent research investigators. The proposed postdoctoral training must offer an opportunity to enhance the applicant&amp;apos;s understanding of the health-related sciences, and must be within the broad scope of biomedical, behavioral, or clinical research or other specific disciplines relevant to the research mission of the participating NIH Institutes and Centers. Applicants with a health professional doctoral degree may use the proposed postdoctoral training to satisfy a portion of the degree requirements for a master&amp;apos;s degree, a research doctoral degree or any other advanced research degree program.NINDS Training and Career Development Officehttp://www.ninds.nih.gov/funding/areas/training_and_career_development/index.htmNINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Stephen Korn, Ph.D.Director of NINDS Training and Career Development Phone: (301) 496-4188Email: NINDSTrainingOffice@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=62</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-110 (F32) Ruth L. Kirschstein National Research Service Awards for Individual Postdoctoral Fellows</category>
						<guid isPermaLink="false">6DC8FC06-78E3-B519-1E4949C4D037ECC8</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PA-10-111 (F33) Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Senior Fellows</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: The individual must have had at least 7 subsequent years of relevant research or professional experience and will have established an independent research career. Application Information: Individual National Research Service Awards (F33) are also available for senior fellows who wish to: (1) make major changes in the direction of their research careers; (2) broaden their scientific background; or (3) acquire new research capabilities. These awards enable individuals beyond the new-investigator stage to take time from regular professional responsibilities to increase their capabilities in health-related research. Senior fellow applications receive the same scientific review as other NRSA applications. The payback requirements for recipients of individual NRSAs are the same as those described in the preceding section for institutional NRSAs. Other: Brandy E Fureman, PhD, Program Director, Epilepsy Research, Channels, Synapses, and Circuits Cluster, National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Health (NIH), Neuroscience Center, Room 2138, 6001 Executive Blvd, Bethesda, MD  20892-9523, 301-496-1917,furemanb@ninds.nih.govStephen Korn, PhDDirector of NINDS Training and Career Development National Institute of Neurological Disorders and Stroke6001 Executive Boulevard, Room 2186, MSC 9531Bethesda, MD 20892 (for courier: Rockville, MD 20852)Phone: (301) 496-4188Email: NINDSTrainingOffice@ninds.nih.gov  or korns@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=95</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PA-10-111 (F33) Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Senior Fellows</category>
						<guid isPermaLink="false">6DC8FC0D-78E3-B519-1E497F9DC753312B</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-08-197 (K12) NEUROLOGICAL SCIENCES ACADEMIC DEVELOPMENT AWARD (NSADA)                                                                                                        SCIENCES</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: PDs/PIs include established clinical-researchers with acknowledged accomplishments in research training, scientific expertise, leadership, and administrative skills.  In addition, eligible PDs/PIs should have a superior record of preparing clinicians for careers as independent researchers. Trainee candidates selected for support as scholars in the K12 program must be U.S. citizens or non-citizen nationals, or individuals lawfully admitted for permanent residence, who hold a medical degree, are licensed to practice medicine in the USA and have been trained in pediatric neurology, and can commit a minimum of 75% of full-time professional effort conducting research, career development, and/or research related activities Application Information: The Neurological Sciences Academic Development Award (NSADA) (K12) is an award to an educational institution or professional organization to support career development experiences for pediatric neurologists leading to research independence. Under this award, newly trained pediatric neurologists are to be selected and appointed to this program by the grantee institution.The NSADA program will support up to three research Scholars for up to a maximum of three years consisting of consecutive 12-month appointmentsThe maximum allowable salary per Scholar is $85,000 per year, and the maximum allowable research costs are $30,000 per year.  The total salary requested for each research candidate must be based on a full-time, 12-month staff appointment. Other: Deborah Hirtz, M.D.Clinical Trials Group Science Leader, Division of Extramural ResearchNational Institute of Neurological Disorders and Stroke/NIH/DHHS6001 Executive Boulevard, Rm. 2212 MSC 9520Bethesda, Maryland  20892-9531Phone: 301-496-9135Fax: 301-480-1080E-mail: dh83f@nih.gov NINDS Training and Career Development OfficerNational Institute of Neurological Disorders and Stroke6001 Executive Boulevard, Room 2154, MSC 9531Bethesda, MD 20892 (for courier: Rockville, MD 20852)Phone: (301) 496-4188FAX: (301) 594-5929Email: NINDSTrainingOffice@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=104</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-08-197 (K12) NEUROLOGICAL SCIENCES ACADEMIC DEVELOPMENT AWARD (NSADA)                                                                                                        SCIENCES</category>
						<guid isPermaLink="false">6DC8FC18-78E3-B519-1E4935EB68AA04FA</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-08-232 (R21) NINDS Exploratory/Developmental Projects in Translational Research</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: 06/01/06, 10/01/06, 02/01/07, 06/01/07, 10/01/07 Eligibility: This PA requests applications for exploratory/developmental projects intended to discover potential targets for therapeutic intervention, to identify candidate therapeutics, to develop assays, animal models, devices, or technologies for screening or developing therapeutics, or to obtain preliminary data on the efficacy of candidate therapeutics. Only Aims required for therapy development can be supported in this program. No basic/mechanistic Aims may be included in the research plan. This funding opportunity will use the R21 award mechanism. The applicant may request a project period of up to two years with a combined budget for direct costs of up $275,000 for the two year period. Application Information: This Funding Opportunity Announcement (FOA) requests applications for projects intended to complete preliminary steps in the pipeline for the pre-clinical development of therapeutics for neurological disorders. Such projects, if successful, should lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application to the Food and Drug Administration (FDA). Only Aims required for therapy development can be supported in this program. This program excludes clinical research, basic research and studies of disease mechanism. This funding opportunity will use the R21 award mechanism.NINDS Office of Translational Research:http://www.ninds.nih.gov/funding/areas/technology_development/index.htmNINDS Epilepsy Research Web:	http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Thomas Miller, Ph.D. Office of Translational ResearchNational Institute of Neurological Disorders and Stroke6001 Executive Boulevard, Room 2139Bethesda, MD 20892Telephone: 301-496-1779FAX: 301-402-1501Email: tm208y@nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=42</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-08-232 (R21) NINDS Exploratory/Developmental Projects in Translational Research</category>
						<guid isPermaLink="false">6DC8FC21-78E3-B519-1E49DF7ACCB84CC1</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-08-233 (U01) NINDS Cooperative Program in Translational Research--Single-Component Research Projects</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Application Information: The purpose is to support pre-clinical development and testing of new therapies for neurological disorders.  The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing.  This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target.  The program supports pre-clinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening.  The program also excludes clinical research, basic research, and studies of disease mechanism.  This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress. Other: Thomas M. Miller, Ph.D., M.B.A.Program Director, Extramural Research ProgramNIH/NINDSNeuroscience Center, Room  21396001 Executive Blvd MSC 9527Bethesda, MD 20892-9527tm208y@nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=96</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-08-233 (U01) NINDS Cooperative Program in Translational Research--Single-Component Research Projects</category>
						<guid isPermaLink="false">6DC8FC29-78E3-B519-1E49C7011D6A1737</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-08-234 (U54) NINDS Cooperative Program in Translational Research--Multi-Component Research Projects</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Application Information: The purpose is to support pre-clinical development and testing of new therapies for neurological disorders.  The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing.  This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target.  The program supports pre-clinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening.  The program also excludes clinical research, basic research, and studies of disease mechanism.  This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress. Other: Thomas M. Miller, Ph.D., M.B.A.Program Director, Extramural Research ProgramNIH/NINDSNeuroscience Center, Room  21396001 Executive Blvd MSC 9527Bethesda, MD 20892-9527tm208y@nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=97</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-08-234 (U54) NINDS Cooperative Program in Translational Research--Multi-Component Research Projects</category>
						<guid isPermaLink="false">6DC8FC31-78E3-B519-1E49280C2C3AD684</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-08-235 (U44) NINDS Cooperative Program in Translational Research Small Business Awards</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDs Application Deadline: null Eligibility: Only United States small business concerns (SBCs) are eligible to submit SBIR applications.  Under the SBIR program, for both Phase I and Phase II, the primary employment of the PD/PI must be with the small business concern at the time of award and during the conduct of the proposed project. For projects with multiple PD/PIs, at least one must meet the primary employment requirement. Application Information: The purpose of the NINDS SBIR Cooperative Agreement (U44) mechanism is to provide support for Phase II, and Fast-Track projects that directly address identification and pre-clinical testing of new therapeutics.  The NINDS Translational Research Program is specifically focused on pre-clinical therapy development necessary to begin clinical testing of therapeutic candidates for neurological disorders. This program supports the pre-clinical development of drugs, biologics, and devices including activities from the identification of a therapeutic lead to Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application to the Food and Drug Administration (FDA). NINDS Office of Translational Researchhttp://www.ninds.nih.gov/funding/areas/technology_development/index.htmMilestones: Phase II applications must include proposed yearly go/no-go milestones that are the subject of a special review criterion. During the execution of the project, NINDS staff will assess progress toward and achievement of milestones. Achievement of these milestones will be evaluated by NINDS prior to releasing funding for each year of the award. Guidance for preparation of milestone plans will be provided by NINDS in pre-application teleconferences and is available at http://www.ninds.nih.gov/funding/research/translational/DevelopingMilestones.htm. Other: Randall R. Stewart, Ph.D. SBIR Program Coordinator National Institute of Neurological Disorders and Stroke 6001 Executive Boulevard, Room 2135Bethesda, MD 20892Telephone: 301-496-1917 FAX: 301-402-1501 Email stewartr@ninds.nih.govThomas Miller, Ph.D.Technology DevelopmentNational Institute of Neurological Disorders and Stroke6001 Executive Boulevard, Room 2139Bethesda, MD 20892Telephone: 301-496-1779FAX: 301-402-1501Email: tm208y@nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=115</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-08-235 (U44) NINDS Cooperative Program in Translational Research Small Business Awards</category>
						<guid isPermaLink="false">6DC8FC3C-78E3-B519-1E4942EC9C60503A</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-08-236 (U24) NINDS Cooperative Program in Translational Research--Resource Centers</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Application Information: The purpose is to implement a program of cooperative agreements that will support milestone-driven resource-related projects focused on providing products and services that are required for the pre-clinical testing of new therapeutics, and that are specific to neurology.http://grants.nih.gov/grants/guide/pa-files/PAR-08-236.html  Expiration Date: September 8, 2011 Other: Thomas M. Miller, Ph.D., M.B.A.Program Director, Extramural Research ProgramNIH/NINDSNeuroscience Center, Room  21396001 Executive Blvd MSC 9527Bethesda, MD 20892-9527tm208y@nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=98</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-08-236 (U24) NINDS Cooperative Program in Translational Research--Resource Centers</category>
						<guid isPermaLink="false">6DC8FC42-78E3-B519-1E49055F6FF0DC80</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-09-065 (K01) Career Development to Promote Diversity in Neuroscience Research</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline:  Eligibility: Eligible principal investigators include those individuals making the transition to an independent scientific career at the senior post-doctoral and junior faculty stages who come from groups that have been shown to be underrepresented in neuroscience research. Such candidates include individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds.  Candidates must be able to commit a minimum of 9 person-months (75% of full-time professional effort) conducting research career development activities associated with this award.  The remaining 3 months (25% effort) can be divided among other research, clinical, and teaching activities only if these activities are consistent with the goals of the K01 award, i.e., the candidates development into an independent investigator. Application Information: The objective of the Career Development Award to Promote Diversity in Neuroscience Research is to promote diversity among faculty-level neuroscience investigators who are competitively funded to conduct independent research. Eligible organizations include domestic for-profit or non-profit organizations, public or private institutions such as universities, colleges, hospitals, and medical, dental, or nursing schools or other institutions of higher education involved in neurological research. Eligible principal investigators include those individuals making the transition to an independent scientific career at the senior post-doctoral and junior faculty stages who come from groups that have been shown to be underrepresented in neuroscience research. Such candidates include individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. Applications will be reviewed based on several criteria including: (1) qualifications of the candidate; (2) the soundness of the proposed career development plan; (3) training in the responsible conduct of research; (4) the nature and scientific/technical merit of the proposed research plan; (5) the qualifications and appropriateness of the mentor/co-mentor; (6) environment and institutional commitment to the candidate&amp;apos;s career; and (7) the strength of the description of how this particular award will promote diversity within the institution or in science nationally. Other: Michelle Jones-London, Ph.D.Program DirectorOffice of Minority Health and ResearchNational Institute of Neurological Disorders and Stroke6001 Executive BlvdNSC, Suite 2149, MSC 9535Bethesda, MD 20892-9535301-451-7966; Fax 301-594-5929jonesmiche@ninds.nih.govBrandy E Fureman Ph.D.Program Director, Epilepsy Research, Channels, Synapses, and Circuits Cluster, National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Health (NIH), Neuroscience Center, Room 2138, 6001 Executive Blvd, Bethesda, MD  20892-9523, 301-496-1917, mj220@nih.gov.  Stephen Korn. Ph.D., Director of Training and Career Development,National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Health (NIH), Neuroscience Center, Room 2186, 6001 Executive Blvd, Bethesda, MD 20892, Phone: (301) 496-4188, korns@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=82</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-09-065 (K01) Career Development to Promote Diversity in Neuroscience Research</category>
						<guid isPermaLink="false">6DC8FC50-78E3-B519-1E49F4BF0625117B</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-09-263 (R01) Ancillary Studies in Clinical Trials of CNS/PNS Disorders ? NINDS Accelerated Awards Program</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Applicants need not be investigators in the parent clinical trial. However, the ancillary principal investigator must document permission to submit from the parent trial leadership (Principal Investigator and Executive Committee).  In general, Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support Application Information: The purpose of this initiative is to encourage and facilitate ancillary studies undertaken in conjunction with on-going NINDS-funded clinical trials of neurological disorders. For a definition of ancillary studies see http://www.ninds.nih.gov/research/clinical_research/policies/ancillary.htm. This funding opportunity will use the R01 award mechanism.NINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htmNINDS Office of Clinical Research:http://www.ninds.nih.gov/research/clinical_research/ Other: Claudia Moy, PhD Office of Clinical Research National Institute of Neurological Disorders and Stroke The Neuroscience Center, Room Number 2214 6001 Executive Blvd Bethesda, MD 20892-9520 Telephone: (301) 496-9135 Fax:(301) 480-1080  Email: MoyC@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=102</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-09-263 (R01) Ancillary Studies in Clinical Trials of CNS/PNS Disorders ? NINDS Accelerated Awards Program</category>
						<guid isPermaLink="false">6DC8FC57-78E3-B519-1E495969EDF07D61</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-10-091 (F31) NINDS Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows in MD-PhD programs</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research training is invited to work with his/her sponsor and institution to develop an application for support. Individuals must be enrolled in both a medical (MD or equivalent) and research (PhD or equivalent) degree granting program to be eligible for this award. Individuals who will have an MD degree prior to enrolling in a PhD program, who wish to apply for support for research training that includes a PhD degree, should respond to the program announcement, NINDS Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows (F32) (PA-09-210). Two other funding opportunities,  the Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (F31) (PA-09-208) and to the Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships (F31) to Promote Diversity in Health-Related Research (PA-09-209), are available to support applicants who are enrolled in programs that will confer research (PhD or equivalent) doctoral degrees only.Support will be provided for all years of full time training leading to the research degree (up to a total of 5 years), so applicants are encouraged to apply early. Applicants may apply during medical school training for activation of this award at the start of research training.  Applicants must show evidence of high academic performance, substantial interest in a research area of high priority to NINDS, and a training program appropriate to the mission of NINDS. Applicants are also encouraged to participate in a research area that provides an opportunity to take advantage of their duel degree training. Application Information: Starting with the April 8, 2010 receipt date, NINDS will use the F31 NRSA mechanism to support MD-PhD students in combined MD-PhD programs. These fellowships will support students for up to 5 years of predoctoral research training. This mechanism does not support medical school education. MD-PhD students are encouraged to apply for F31 support as early in their careers as possible, potentially as early as the end of the medical school year prior to beginning research. Applicants must have identified a lab, mentor(s) and research project. However, preliminary data and/or publications from the graduate lab are not required for a competitive application. Peer review evaluation is described in detail in the funding opportunity announcement. Emphasis will be placed on the quality of the research being done in the chosen lab, the creativity of the applicant&amp;amp;#8217;s proposed research project, the career development/training plan and the training track record of the mentorship team. Applicants are STRONGLY encouraged to contact the NINDS Training Office before preparing an application, as NINDS will consider only those applications that are designed to support the training and development of scientists with interests relevant to the mission of NINDS. Eligible applicants must be enrolled in an MD program at an accredited medical school, accepted in a related scientific PhD program, and supervised by a mentor in that scientific discipline when the application is submitted. Other: Stephen KornDirector of NINDS Training and Career Development National Institute of Neurological Disorders and Stroke6001 Executive Boulevard, Room 2186, MSC 9531Bethesda, MD 20892 (for courier: Rockville, MD 20852)Phone: (301) 496-4188Email: NINDSTrainingOffice@ninds.nih.gov  or korns@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=114</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-10-091 (F31) NINDS Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows in MD-PhD programs</category>
						<guid isPermaLink="false">6DC8FC67-78E3-B519-1E49B91F046502C8</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-10-143 (R21) NINDS Exploratory/Developmental Projects in Translational Research for Resistant Epilepsy and Epileptogenesis</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Application Information: This funding opportunity announcement (FOA), from the National Institute of Neurological Disorders and Stroke (NINDS) encourages applications for projects intended to complete preliminary steps in the pipeline for the preclinical development of therapeutics to cure epilepsy, prevent the emergence of epilepsy following brain injury (including status epilepticus, traumatic brain injury, stroke, encephalitis, or other injury) or in other high-risk groups, or to better treat individuals with intractable epilepsy.  Such projects, if successful, should lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application to the Food and Drug Administration (FDA). Only Aims required for therapy development can be supported in this program. This program excludes clinical research, basic research, and studies of disease mechanisms.The NINDS funding plan for this FOA will support up to $900,000 total costs, which is sufficient for at least one new application per year for 3 years.NINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Randall Stewart, PhD Division of Extramural Research National Institute of Neurological Disorders and Stroke 6001 Executive Blvd, Room 2135 Bethesda, MD 20892 Telephone: (301) 496-1917 Fax: (301) 402-1501Email: StewartR@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=108</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-10-143 (R21) NINDS Exploratory/Developmental Projects in Translational Research for Resistant Epilepsy and Epileptogenesis</category>
						<guid isPermaLink="false">6DC8FC70-78E3-B519-1E49BF094CF9E3C1</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>PAR-10-144 (U01) NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Application Information: The goal of this funding opportunity announcement (FOA), from the National Institute of Neurological Disorders and Stroke (NINDS) is to support preclinical development of new therapies to cure epilepsy, prevent the emergence of epilepsy following brain injury (including status epilepticus, traumatic brain injury, stroke, encephalitis, or other injury) or in other high-risk groups, or to better treat individuals with intractable epilepsy.  The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target. The program supports preclinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research, basic research, and studies of disease mechanism. This is a milestone-driven cooperative agreement program involving participation of NIH staff in the development of the project plan and monitoring of research progress.NINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Randall Stewart, PhD Division of Extramural Research National Institute of Neurological Disorders and Stroke 6001 Executive Blvd, Room 2135 Bethesda, MD 20892 Telephone: (301) 496-1917 Fax: (301) 402-1501Email: StewartR@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=109</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>PAR-10-144 (U01) NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis</category>
						<guid isPermaLink="false">6DC8FC79-78E3-B519-1E49125EF03FF8A6</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Pfizer&apos;s Medical and Academic Partnerships Program</title>
						
						<description><![CDATA[Sponsor: Pfizer Source: Pfizer Application Deadline: null Eligibility: therapeutic clinicians and academic researchers in basic, outcomes, and patient-oriented research Application Information: clinical and/or research fellowships If you require assistance or have questions regarding your pending application, please do not hesitate to contact us at (877) 254-6953 or MAPInfo@clinicalconnexion.com. Other: Each Medical &amp;amp; Academic Partnerships award area has an independent academic selection committee comprised of leaders in the program&amp;amp;#8217;s field. This committee selects the recipients of these nationally competitive awards and helps shape the structure and scope of future programs to maximize their impact.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=118</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Pfizer&apos;s Medical and Academic Partnerships Program</category>
						<guid isPermaLink="false">6DC8FC7E-78E3-B519-1E496E20E1164245</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Phelan-McDermid Syndrome Foundation Post-Doctoral Fellowship</title>
						
						<description><![CDATA[Sponsor: Phelan-McDermid Syndrome Foundation Source: Phelan-McDermid Syndrome Foundation Application Deadline: null Eligibility: Applicants should have training and experience at least equal to the Ph.D. or M.D. level.   The selected postdoctoral fellow must spend at least 90% of his/her professional time engaged exclusively in PMS research related activities for the duration of the award. Application Information: The Phelan-McDermid Syndrome Foundation (PMSF) is accepting fellowship applications for research related to Phelan-McDermid Syndrome (PMS), also known as 22q13 Deletion Syndrome, and SHANK3, one of the most promising autism candidate genes.  PMSF&amp;amp;#8217;s grants and fellowships program is intended to encourage research projects that will advance the development of treatments and cures for PMS.  Applications must demonstrate direct relevance to at least one of these targeted research priorities:  &amp;amp;#8226;	Identification of the molecular pathophysiology of PMS that can inform translational research for drug discovery &amp;amp;#8226;	Development and evaluation of novel treatments that can address the core symptoms and associated medical (including psychiatric) conditions of PMS throughout the lifespan&amp;amp;#8226;	Development of evidence-based clinical care recommendations for PMS Other: One year, renewable for second year, based on satisfactory progress.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=121</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Phelan-McDermid Syndrome Foundation Post-Doctoral Fellowship</category>
						<guid isPermaLink="false">6DC8FC85-78E3-B519-1E49BD06D479B5FE</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Post-Doctoral Research Training Fellowship Program</title>
						
						<description><![CDATA[Sponsor: AES/UCB Pharma Source: AES/Epilepsy Foundation Application Deadline: September 1 Eligibility: This program has been closed indefinitely. Physicians or Ph.D. Neuroscientists who desire postdoctoral research experience Application Information: This program has been closed indefinitely.Application form and more information available on the Epilepsy Foundation web site. See link above. Other: Ofers opportunity to develop expertise in epilepsy research. May be either basic or clinical but must address a question of fundamental importance to epilepsy.  Preceptor supervision required.Not funded for 2009/2010 fiscal year.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=11</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Post-Doctoral Research Training Fellowship Program</category>
						<guid isPermaLink="false">6DC8FC89-78E3-B519-1E49AA3D556D8A7D</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Postdoctoral Fellowship</title>
						
						<description><![CDATA[Sponsor: Tuberous Sclerosis Alliance Source: Tuberous Sclerosis Alliance Application Deadline: TBA Eligibility: Open to all investiagors at established academic and/or research institutions worldwide.  Researchers residing in the U.S.A. do not need to be U.S. citizens to apply. Application Information: Before submitting an application for research support, an applicnt must submit a Letter of Intent (LOI) briefly describing the project.  If the research proposed in the LOI meets the TS Alliance&amp;apos;s funding priorities in a given year, the investigator will be invited to submit a formal proposal.  The TS Alliance Grant Review Committee carefully reviews all LOIs submitted for review.Deadline for Letter of Intent: November 1, 2008Deadline for Receipt of Completed Application: February 1, 2009Awards Announced: June 2009Earliest Project Start Date: July 1, 2009 Other: Designed to provide funding for a Principal Investigator working closesly with a Sponsor to do research on TSC focused on:Research that is essential to develop and test new therapies, treatments, education and/or neuropsychological programs for individuals with TSC and/or LAM; and/orResources necessary to answer these essential questions (animal models, new imaging modalities, databases, etc.)]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=31</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Postdoctoral Fellowship</category>
						<guid isPermaLink="false">6DC8FC90-78E3-B519-1E4962B16506D674</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Postdoctoral Research Fellowship</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline: September 1 Eligibility: Physicians or Ph.D. neuroscientists who desire postdoctoral research experience are eligible to apply. Application Information: The Postdoctoral Research Fellowship develops academic physicians and scientists committed to research related to epilepsy. Applications are considered equally from individuals interested in acquiring experience either in basic laboratory research or in the conduct of human clinical studies. Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=18</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Postdoctoral Research Fellowship</category>
						<guid isPermaLink="false">6DC8FC95-78E3-B519-1E496622FC699711</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Predoctoral Fellowship</title>
						
						<description><![CDATA[Sponsor: Tuberous Sclerosis Alliance Source: Tuberous Sclerosis Alliance Application Deadline: TBA Eligibility: Graduate student working in academic or research laboratory.  U.S. citizenship not required. Application Information: Before submitting an application for research support, an applicant must submit a Letter of Intent (LOI) briefly describing the project.  If the researrch proposed in the LOI meets the TS Alliance&amp;apos;s funding priorities in a given year, the investigator will be invited to submit a formal proposal.  The TS Alliance Grant Review Committee carefullly reviews all LOIs submitted for review. Other: Designed to provide funding for a Principal Investigator working closely with a Sponsor to do research on the TSC focused on: Research that is essential to develop and test new therapies, treatments, educational and/or neurpsychological programs for individuals with TSC and/or LAM; and/orResources necessary to answer these essential questions (animal models, new imaging modalities, databases, etc.)]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=32</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Predoctoral Fellowship</category>
						<guid isPermaLink="false">6DC8FC9B-78E3-B519-1E49807DAE961233</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Predoctoral Research Training Fellowship</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline: September 1 Eligibility: Graduate students pursuing a Ph.D. degree in neuroscience, physiology, pharmacology, psychology, biochemistry, genetics, nursing, or pharmacy may apply. Application Information: The Predoctoral Research Training Fellowship supports pre-doctoral students with dissertation research related to epilepsy, thus strengthening their interest in establishing epilepsy research as a career direction. Graduate students pursuing a Ph.D. degree in neuroscience, physiology, pharmacology, psychology, biochemistry, genetics, nursing, or pharmacy may apply. Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=17</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Predoctoral Research Training Fellowship</category>
						<guid isPermaLink="false">6DC8FCA0-78E3-B519-1E497A69CB9DA5D3</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research &amp; Training Workshops</title>
						
						<description><![CDATA[Sponsor: AES Source: AES Application Deadline: March 15 and October 14 Eligibility: Organizer of a targeted workshop intended for broad-based, national clinical or scientific audiences and on specific collaborative consensus or review topics in neuroscience that are novel and creative. Usually associated with an academic institution or professional society. Application Information: Applications for grants will be considered annually during two rounds. The deadline for the first round of grants is March 9th. Deadline for the second round is October 26th. Any applications received after the deadlines will be held until the following round of grants. Denied applications will not be automatically reconsidered for funding. To be reconsidered a new application must be submitted. Other: For additional information please visit https://www.aesnet.org/go/research/research-awards/research-and-training-workshops]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=8</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research &amp; Training Workshops</category>
						<guid isPermaLink="false">6DC8FCA6-78E3-B519-1E4964413238417B</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research &amp; Training Workshops</title>
						
						<description><![CDATA[Sponsor: AES Source: AES Application Deadline: null Eligibility: Organizer of a targeted workshop intended for broad-based, national clinical or scientific audiences and on specific collaborative consensus or review topics in neuroscience that are novel and creative. Usually associated with an academic institution or professional society. Application Information: Applications for grants will be considered annually during two rounds. The deadline for the first round of grants is March 11th. Deadline for the second round is October 28th. Any applications received after the deadlines will be held until the following round of grants. Denied applications will not be automatically reconsidered for funding. To be reconsidered a new application must be submitted. Other: For more information go to https://www.aesnet.org/go/research/research-awards/research-and-training-workshops]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=106</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research &amp; Training Workshops</category>
						<guid isPermaLink="false">6DC8FCAB-78E3-B519-1E491247C231BC0F</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research and Training Fellowships for Clinicians</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline: October 14, 2005 Eligibility: This fellowship is one-year of supervised study and research. Individuals with an MD or DO who will have completed residency training in neurology, neurosurgery, pediatrics, internal medicine, or psychiatry by the time the fellowship commences may apply. Other clinically trained professionals (i.e. PharmD, Doctor of Nursing) are also eligible to apply. A letter of intent is not required. Application Information: The Research and Training Fellowships for Clinicians is a postdoctoral fellowship program for clinically trained professionals. Other: (Maximum $100,000/two years)]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=19</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research and Training Fellowships for Clinicians</category>
						<guid isPermaLink="false">6DC8FCB0-78E3-B519-1E491F3D12642128</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research Funding</title>
						
						<description><![CDATA[Sponsor: faces Source: faces Application Deadline: 0 Eligibility: FACES is involved in intensive research efforts that will minimize the effects of and, we hope one day, find a cure for epilepsy. New and exciting projects are underway, or in exploratory stages, that will introduce new equipment, monitoring devices and medications. A non-profit organization affiliated with NYU Medical Center and its Comprehensive Epilepsy Center Application Information: To learn more about our research efforts, visit the research page of the NYU Comprehensive Epilepsy Center (http://www.med.nyu.edu/faces/) or email facesinfo@nyumc.org Other: A non-profit organization affiliated with NYU Medical Center and its Comprehensive Epilepsy Center.  For a description of projects funded in the past go to http://www.med.nyu.edu/faces/research]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=27</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research Funding</category>
						<guid isPermaLink="false">6DC8FCB5-78E3-B519-1E49E712EEF95045</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research Grant</title>
						
						<description><![CDATA[Sponsor: Pediatric Neurotransmitter Disease (PND) Association Source: Pediatric Neurotransmitter Disease (PND) Association Application Deadline: null Eligibility: The Pediatric Neurotransmitter Disease (PND) Association is pleased to announce the availability of up to $200,000 in grant awards for research involving the detection, diagnosis, and/or treatment of diseases related to neurotransmitter metabolism. Application Information: Go to http://www.pndassoc.org/grants for details Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=100</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research Grant</category>
						<guid isPermaLink="false">6DC8FCB8-78E3-B519-1E4933E180194311</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research Grant program</title>
						
						<description><![CDATA[Sponsor: PACE Source: PACE Application Deadline: September 15, 2006 Eligibility: PACE funds research on an annual basis. Every May there will be a Research Grant Screening Application available online for researchers interested in applying for a research grant for the following year. Application Information: pacenyemail@aol.com Other: For a listing of funded programs go to: http://www.paceusa.org/indexframe2.html]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=26</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research Grant program</category>
						<guid isPermaLink="false">6DC8FCBC-78E3-B519-1E4982966DB91B40</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research Grants</title>
						
						<description><![CDATA[Sponsor: People Against Childhood Epilepsy, Inc. (PACE) Source: PACE Application Deadline: null Eligibility: PACE will consider grant applications for innovative research to encourage investigation into the causes and cures of seizure disorders in children Application Information: PACE will consider grant applications for innovative research to encourage investigation into the causes and cures of seizure disorders in children.The primary areas of research we are interested in stimulating are:* Innovative pediatric models of epilepsy* Research that is readily translatable to treatments or therapies* Evaluation of neocortical epilepsies*  The role of immune or inflammatory mediators in epilepsy*  Neuro immunological effects of inflammatory molecules with the emphasis on dietary pathogens*  Other innovative proposals that fall outside the above areas that address pediatric epilepsy will be considered including quality of life Other: To get a copy of the screening application, please go to paceusa.org.Applications must be filed and received by September 18, 2009.You can reach us: online www.paceusa.org, e-mail pacenyemail@aol.com, fax 212.327.3075, phone 212.665.PACE (7223)]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=101</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research Grants</category>
						<guid isPermaLink="false">6DC8FCC2-78E3-B519-1E49E9AA5AA9AD1B</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research Grants Program</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline:  Eligibility: Seed grants are awarded to clinical investigators or basic scientists for support of biological or behavioral research which will advance the understanding, treatment, and prevention of epilepsy. Applications from established investigators (Associate Professor level or above) are ineligible. Application Information: The Research Grants Program stimulates epilepsy research by providing funding for investigators in the early stages of their careers. Other: (Maximum $100,000/two years)]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=83</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research Grants Program</category>
						<guid isPermaLink="false">6DC8FCC6-78E3-B519-1E492A16B90CAE6E</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research Infrastructure Awards</title>
						
						<description><![CDATA[Sponsor: AES/Epilepsy Foundation Source: AES Application Deadline: March 15 Eligibility: 2012 Deadlines: Letter of Intent due August 20th. If selected, full application due November 1st.1. Multicenter (defined as three or more)2. Innovative (exploring new concepts, new techniques, different approaches to significant problems in the epilepsy field - high rish/high gain studies are consistent with this criterion)3.  Aimed at developing a new collaborative research program  and collecting preliminary results for an NIH grant application.4. Viewed as important research5. Likely to lead to significant research programs that will be funded from other (e.g. NIH) sources. Application Information: Application is done in two parts.  Electronic submission required.Letter of intent due August 20 see web liink above for details.  Notification of acceptance will be made by October 5th.  Selected candidates will be invited to submit a complete application by Novwmber 1, 2012. Other: Awards will be based on proposed budget and are anticipated to be up to $50,000 per year.  A competing renewal application (progress report) is required for the second year of funding. These funds are meant to be used to support pilot projects and hold organizational and planning sessions, develop the research effort and collect results that would be used to prepare and submit a larger applictaion for support from the Federal Government and establish the multicenter research program over the long term.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=10</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research Infrastructure Awards</category>
						<guid isPermaLink="false">6DC8FCCE-78E3-B519-1E49B02F660E8235</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Research Initiative Awards</title>
						
						<description><![CDATA[Sponsor: AES Source: AES Application Deadline: September 1 Eligibility: AES members who are established investigators. &amp;quot;Established&amp;quot; means associate professor level and above, or assistant professor with secure grant funding. Deadline for Letter of Intent is August 20, 2012.  If selected, the deadline for full application will be November 1, 2012. Application Information: Two part application processLetter of intent due August 20 sent electronically.  See above web link for details.Notification of acceptance will be made by October 5th.Selcted applications must submit complete application package by November 1.Funding notifcation will happen in December. Other: Awards will be made based on the proposed budget, with an anticipated award of $30,000- $50,000 per project. Up to three projects will be funded each year. Only AES members are eligible to apply as PI (although not all participating collaborators must be AES members). For more information, please visit http://www.aesnet.org/go/research/research-awards/research-initiative-awards]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=6</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Research Initiative Awards</category>
						<guid isPermaLink="false">6DC8FCD4-78E3-B519-1E49965CA20D2C63</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>RFA-GM-10-009  (R01) Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA)</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/ organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support Application Information: This funding opportunity will use the R01 award mechanismThis announcement solicits Research Project Grant (R01) applications from institutions/organizations proposing exceptionally innovative research on novel hypotheses or difficult problems, solutions to which would have an extremely high impact on biomedical or biobehavioral research that is germane to the mission of one or more of the participating NIH Institutes. This announcement is for support of new projects, not continuation of projects that have already been initiated. It does not support pilot projects, i.e., projects of limited scope that are designed primarily to generate data that will enable the PI to seek other funding Other: Edmund Talley, Ph.D. National Institute of Neurological Disorders and Stroke 6001 Executive Blvd., Room 2132 Bethesda, MD 20892-9531Telephone: (301) 496-1917 Fax: (301) 402-1501 Email: talleye@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=103</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>RFA-GM-10-009  (R01) Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA)</category>
						<guid isPermaLink="false">6DC8FCDB-78E3-B519-1E4917EB4AAC8C1B</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>RFA-NS-11-003 (R01) Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) In the Epilepsies</title>
						
						<description><![CDATA[Sponsor: NINDS Source: NINDS Application Deadline: null Eligibility: Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Application Information: This FOA solicits Research Project Grant (R01) applications from institutions/organizations proposing exceptionally innovative research on novel hypotheses or difficult problems, solutions to which would have an extremely high impact on biomedical or biobehavioral research in the epilepsies. This FOA is for support of new projects, not continuation of projects that have already been initiated. It does not support pilot projects, i.e., projects of limited scope that are designed primarily to generate data that will enable the PI to seek other funding opportunities.Letter of Intent Receipt: Date July 13, 2010NINDS intends to commit up to $2 million total costs in fiscal year 2011 to support 4-6 new awards under this FOA.NINDS Epilepsy Research Web:http://www.ninds.nih.gov/funding/research/epilepsyweb/index.htm Other: Brandy Fureman, PhD National Institute of Neurological Disorders and Stroke Room 2138 6001 Executive Blvd Bethesda, MD 20892-9529 (Rockville, MD 20852 for express/courier service)Telephone: (301) 496-1917 Fax: (301) 402-1501Email: furemanb@ninds.nih.govRandall Stewart, PhD National Institute of Neurological Disorders and Stroke Room 21356001 Executive Blvd Bethesda, MD 20892-9529 (Rockville, MD 20852 for express/courier service)Telephone: (301) 496-1917 Fax: (301) 402-1501Email: stewartr@ninds.nih.gov]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=110</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>RFA-NS-11-003 (R01) Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) In the Epilepsies</category>
						<guid isPermaLink="false">6DC8FCE3-78E3-B519-1E49B66379B1FC76</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Susan S. Spencer Clinical Research Training Fellowship in Epilepsy</title>
						
						<description><![CDATA[Sponsor: American Academy of Neurology Foundation, AES and Epilepsy Foundation Source: AAN Application Deadline: null Eligibility: Applicant must be an AAN member interested in an academic career in clinical research who has completed residency or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority. Application Information: Applications are evaluated by members of the AAN Clinical Research Subcommittee, Translational Neuroscience Subcommittee, and various ad-hoc reviewers based on the following criteria:1. Applicant&amp;apos;s ability and promise as a clinician-scientist based on prior record of achievement adn career plan, letters of reference, and curriculum vitae (30%).2.  Quality and nature of the training to be provided and the institutional, departmental, and mentor-specific training environment (30%).3. Quality and originality of the research plan (40%). Other: All applications and supporting materials must be received by October 1, 2012. Notification of recipients: January 2013.  All materials must be submitted online. Detailed instructions are available at www.aan.com/view/CRTF.Each fellowship will consist of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant&amp;apos;s institution or elsewhere.]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=120</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Susan S. Spencer Clinical Research Training Fellowship in Epilepsy</category>
						<guid isPermaLink="false">6DC8FCEB-78E3-B519-1E497A6B6238B147</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Targeted Research Initiative for Health Outcomes</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline:  Eligibility: Hold a Doctor of Medicine, Doctor of Philosophy, Doctor of Science, or equivalent degree (eligibility of other doctoral level degrees, e.g. PharmD, may be considered); and have an academic appointment that is at least at the level of Assistant Professor in a university or medical school, or equivalent standing at a research institution or medical center.Applicants may request up to $75,000 for one year. Grants awarded for higher than $50,000 are based on funds available and may be offered if the applicant proposes particularly meritorious work. Application Information: This initiative targets an important need for research to understand how different components of health care systems affect outcomes in people with epilepsy. The purpose of this initiative is to support research that generates initial data leading to more extensive projects that will generate knowledge that will ultimately improve the healthcare of persons with epilepsy. The broad focus of the proposal includes methodological aspects of health and outcome measurement, health care needs assessment, nature and determinants of disparities in healthcare and methods of health care delivery. Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=80</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Targeted Research Initiative for Health Outcomes</category>
						<guid isPermaLink="false">6DC8FCF1-78E3-B519-1E4989766C4921FF</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Targeted Research Initiative for Mood Disorders</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline: March 1, 2006 Eligibility: Investigators must hold a relevant advanced degree (M.D. and/or Ph.D.) and have completed all research training. Open to investigators based at corporations as well as academic/university settings, pilot grants will be awarded up to $100,000 for one year. Grants awarded for higher than $50,000 are based on funds available and may be offered if the applicant proposes particularly meritorious work. Application Information: The Targeted Research Initiative for Mood Disorders supports research leading to new insights into the diagnosis etiology, complications and treatment of persons with epilepsy and mood disorders. Both clinical and basic projects are of interest, using a variety of disciplinary approaches. While not a requirement of this solicitation, priority will be given to Spring 2008 proposals addressing studies of children and adolescents, co-morbid anxiety and depression, or translational/interventional research relevant to epilepsy and mood disorders. Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=21</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Targeted Research Initiative for Mood Disorders</category>
						<guid isPermaLink="false">6DC8FCF7-78E3-B519-1E4944A85163DCE4</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Targeted Research Initiative for Seniors</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundaton Application Deadline:  Eligibility: Investigators must hold a relevant advanced degree (M.D. and/or Ph.D.) and have completed all research training. Open to investigators based at corporations as well as academic/university settings, pilot grants will be awarded up to $100,000 for one year. Grants awarded for higher than $50,000 are based on funds available and may only be offered if the applicant proposes particularly meritorious work. Application Information: The Targeted Research Initiative for Seniors supports the development of piolet data that can lead to sponsored research projects in the future. Areas of interest include: fundamental knowledge of aging and epilepsy, diagnosis of partial seizures in the elderly and therapeutics in the elderly. Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=69</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Targeted Research Initiative for Seniors</category>
						<guid isPermaLink="false">6DC8FCFC-78E3-B519-1E4960E17A604530</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>Targeted Research Initiative for Youth</title>
						
						<description><![CDATA[Sponsor: Epilepsy Foundation Source: Epilepsy Foundation Application Deadline: null Eligibility: Hold a Doctor of Medicine, Doctor of Philosophy, Doctor of Science, or equivalent degree (eligibility of other doctoral level degrees, e.g. PharmD, may be considered); and have an academic appointment that is at least at the level of Assistant Professor in a university or medical school, or equivalent standing at a research institution or medical center.Applicants may request up to $75,000 for one year. Grants awarded for higher than $50,000 are based on funds available and may be offered if the applicant proposes particularly meritorious work. Application Information: This program recognizes the increasing need for epilepsy and seizure research in populations from children through adolescence involving pathophysiology, epidemiology, diagnosis, behavioral manifestations, medication therapy, and quality-of-life issues.  The Epilepsy Foundation supports fundamental, translational and clinical research leading to advances into the diagnosis and care of youth with seizures and epilepsy. Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=89</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>Targeted Research Initiative for Youth</category>
						<guid isPermaLink="false">6DC8FD02-78E3-B519-1E491F45CB1AA134</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>TSC Innovator Grant Awards</title>
						
						<description><![CDATA[Sponsor: Tuberous Sclerosis Alliance Source: Tuberous Sclerosis Alliance Application Deadline: TBA Eligibility: TSC Innovator Grant Awards are designed to provide funding for established researchers with a PhD and/or MD degree for research focused on:Research that is essential to develop and test new therapies, treatments and/or neuropsychological programs for individuals with TSC and/or LAM; and/orResources necessary to answer these essential questions (animal models, new imaging modalites, databases, etc.)Open to all investigators at established academic and/or research institutions worldwide. Application Information: Before submitting an application for research support, an applicant must submit a Letter of Intent (LOI) briefly describing the project.  If the reaserch proposed in the LOI meets the TS Alliance&amp;apos;s funding priorities in a given year, the investigator will be invited to submit a formal proposal.  The TS Alliance Grant Committee carefully reviews all LOIs submitted for review.Deadline for receipt of Letter of Intent: November 1, 2008Deadline for Reciept of Completed Application: February 1, 2009 Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=30</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>TSC Innovator Grant Awards</category>
						<guid isPermaLink="false">6DC8FD08-78E3-B519-1E498CFECF0EB830</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>TSC Supplemental Grant Awards</title>
						
						<description><![CDATA[Sponsor: Tuberous Sclerosis Alliance Source: Tuberous Sclerosis Alliance Application Deadline: null Eligibility: TSC Supplemental Grant Awards are designed to provide supplemental funding for establised researchers with a PhD and/or MD degree who have received funding from another funding source (NIH, DOD, etc.), but who need additional funding to carry out the proposed research.  Open to investigators at established academic and/or research institutions worldwide.  Researchers residing in the U.S.A. do not need to be U.S. citizens to apply. Application Information: An applicant must submit a copy of the original grant application describing the project, the grant review from the funding agency (NIH, DOD, etc.), and a funding request to the TS Alliance.  The TS Alliance Grant Review Committee carefully reviews all proposals.Deadline for Submission: November 1, 2008 Other: This research should be focused on:Research that is essential to develop and test new therapies, treatments, educational and/or neuropsychological programs for individuals with TSC and/or LAM;Resources necessary to answer these essential questions (animal models, new imaging modalities, databases, etc.)This grant mechanism is NOT designed to support:Clinical trailsSupport for predoctoral students, postdoctoral or clinical fellows]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=87</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>TSC Supplemental Grant Awards</category>
						<guid isPermaLink="false">6DC8FD0F-78E3-B519-1E492C456CC27718</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
					<item>
						<title>TSC Workshop/Conference Awards</title>
						
						<description><![CDATA[Sponsor: Tuberous Sclerosis Alliance Source: Tuberous Sclerosis Alliance Application Deadline: null Eligibility: Open to investigators at established academic and research institutions.  All conferences are to be held within the contiguous states of the U.S.A. (unless prior approval from the TS Alliance for a foreign site), and planned in partnership with the TS Alliance. Application Information: Before submitting an application for conference support, an applicant must submit a Letter of Intent (LOI) briefly describing the project.  If the research proposed in the LOI meets the TS Alliance&amp;apos;s funding priorities in a given year, the investigator will be invited to submit a formal proposal.  The TS Alliance Grant Review Committee carefully reviews LOIs submitted by the deadline.Deadline for Letter of Intent: November 1, 2008Deadline for Completed Applications: February 1, 2009 Other: ]]></description>
						
						<link>http://www.aesnet.org/erc/funding/details.cfm?oppid=86</link>
						<author>info@aesnet.org (Resources in Epilepsy Research (AES))</author>
						<category>TSC Workshop/Conference Awards</category>
						<guid isPermaLink="false">6DC8FD14-78E3-B519-1E494CA6524CC6D6</guid>
						<pubDate>Wed, 16 May 2012 06:32:01 EST</pubDate>
					</item>
				
				</channel>
			</rss>
